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Genomics and genetics have invaded all aspects of biology and medicine, opening uncharted territory for
scientiﬁc exploration. The deﬁnition of “gene” itself has become ambiguous, and the central dogma is
continuously being revised and expanded. Computational biology and computational medicine are no
longer intellectual domains of the chosen few. Next generation sequencing (NGS) technology, together
with novel methods of pattern recognition and network analyses, has revolutionized the way we think
about fundamental biological mechanisms and cellular pathways. In this review, we discuss NGS-based
genome-wide approaches that can provide deeper insights into retinal development, aging and disease
pathogenesis. We ﬁrst focus on gene regulatory networks (GRNs) that govern the differentiation of
retinal photoreceptors and modulate adaptive response during aging. Then, we discuss NGS technology
in the context of retinal disease and develop a vision for therapies based on network biology. We should
emphasize that basic strategies for network construction and analyses can be transported to any tissue or
cell type. We believe that speciﬁc and uniform guidelines are required for generation of genome, tran-
scriptome and epigenome data to facilitate comparative analysis and integration of multi-dimensional
data sets, and for constructing networks underlying complex biological processes. As cellular homeo-
stasis and organismal survival are dependent on geneegene and geneeenvironment interactions, we
believe that network-based biology will provide the foundation for deciphering disease mechanisms and
discovering novel drug targets for retinal neurodegenerative diseases.
Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Contents
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Ramon y Cajal was the ﬁrst to recognize the retina as ‘a true
nervous center, as a peripheral extension of the central nervous
system’ (Ramon y Cajal, 1893 La retine des Vertebres; translation
taken from Piccolino 1989 Santiago Ramon Y Cajal, the retina and
the neuron theory). The retina has thus attained the distinction of
being an attractive model to investigate fundamental biology and
therapy of the nervous system. The vertebrate retina is composed of
six major neuronal cell types that are organized in three cellular
layers forming exquisite neuronal circuits for detection of visual
information (Fig. 1A). Light is captured by photoreceptors; visual
signals then undergo enhancement, integration and processing
through bipolar, horizontal and amacrine cells and by varied usage
of parallel synaptic circuits, before eventually being transmitted via
ganglion cells to the brain (Lamb et al., 2007; Masland, 2001). This
remarkable complexity makes the retina extremely vulnerable to
degeneration caused by genetic defects that eventually lead to
vision loss. In fact, a vast majority of incurable blindness is caused
by dysfunction or death of retinal photoreceptors (Wright et al.,
2010). Thus, knowledge-based design of therapies for blinding
retinal degenerative diseases (RDDs) depends on better under-
standing of pathways that are associated with: (i) normal devel-
opment of the retinal neurons (speciﬁcally photoreceptors) from
progenitors and stem cells; (ii) assembly of synaptic circuits; (iii)
cellular adaptation and homeostasis; (iv) response to aging and
inherited genomic changes; and (v) disease pathogenesis.
The human genome of almost three billion nucleotides contains
the complete instruction for generating over 100 billion neurons and
150 trillion synapses (Pakkenberg et al., 2003; Williams and Herrup,1988). Despite tremendous cellular heterogeneity and functional
complexity, our genome encompasses only approximately 20,000
protein-coding genes (Ezkurdia et al., 2014) (http://www.
gencodegenes.org), fewer than some of the “apparently” less-
evolved organisms (Carninci et al., 2005; de Laat and Duboule,
2013; Pruitt et al., 2009). However, alternative splicing and use of
alternate promoters can produce unique gene expression patterns
associated with fate determination and cell-type speciﬁc functions
(Wang et al., 2008). Furthermore, the non-protein-coding genomic
DNA [the so-called “junk DNA” (Balakirev and Ayala, 2003; Brosius
and Gould, 1992; Ohno, 1972)] is increasingly being recognized as
an important “regulator” of the coding information (Palazzo and
Gregory, 2014). Cis-regulatory sequences include the genomic code
for binding of transcription complexes that dictate quantitatively
preciseaswell as cell type- and stage-speciﬁc geneexpression (Levine
et al., 2014; Shlyueva et al., 2014). In addition, though the coding
transcripts are relatively small innumber, a plethora of small and long
non-coding RNAs are detected in different cell types and believed to
modulate gene expression and homeostasis (Morris and Mattick,
2014; Slack, 2006). Normal gene expression patterns, established by
combinatorial action of multiple regulatory modules, can be dis-
rupted in response to changes in microenvironment and/or by
inherited genomic variations/mutations, resulting in altered physi-
ology and phenotype (including disease) (Lagha et al., 2012). Thus,
comprehensive understanding of integrated gene regulatory net-
works (GRNs) is critical for deciphering normal development and
homeostatic mechanisms as well as pathways leading to disease.
Remarkable advances have been made in elucidating molecules
and pathways that control retinal cell fate speciﬁcation and dif-
ferentiation (Agathocleous and Harris, 2009; Bassett and Wallace,
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inherited monogenic RDDs (RetNet; https://sph.uth.edu/retnet/).
We have also begun to dissect the complexities of multifactorial
retinal diseases that afﬂict large segments of the population
(Fritsche et al., 2014; Kuo et al., 2014). Impressive gene- and stem
cell-based approaches are being developed for treatment of retinal
disease; nonetheless, individual research projects have generally
centered on single genes or molecules or on a single functional
pathway, and therefore the biomedical progress has not been able
to keep pace with public expectations (Bull and Martin, 2011;
Cuenca et al., 2014; Lindvall and Kokaia, 2010; Rowe-Rendleman
et al., 2014). We must recognize that genes/RNAs/proteins are
part of complex molecular networks and biochemical pathways
and that the disruption of one creates a domino effect leading to
multiple changes (including in gene expression patterns) not only
within the affected cell(s) but also in neighboring cells and tissues.
Therefore, holistic assessment of biological components and of
interaction networks constitutes essential tasks in exploring retinal
development and disease in the post-genomic era (Barabasi and
Oltvai, 2004; Hwang et al., 2012; Kitano, 2002; Schadt, 2009;
Vidal et al., 2011; Yu et al., 2004b; Zhou et al., 2014).
The emergence of next generation sequencing (NGS) technology
has dramatically broadened the scope in which diverse cellular
processes can be interrogated, setting the stage for system-level
approaches to comprehend retinal GRNs. In this review, we will
describe the current status of genome-wide strategies as applied to
the retina and discuss in which direction the ﬁeld appears to be
moving. As the task ahead is daunting yet feasible, we believe that a
collaborative consortium-like approach, elegantly demonstrated by
genetic studies of age-related macular degeneration (AMD)
(Cipriani and International AMD Genomics Consortium, 2014;
Fritsche et al., 2013; Fritsche and International AMD Genomics
Consortium, 2014), is required to elucidate retinal GRNs that con-
trol development, maintain homeostasis and modulate responses
to aging, environment and inherited disease-causing variants or
mutations. We have therefore taken the liberty to put forward a
framework for integrative and comparative analysis of NGS data,
with a goal to build comprehensive GRNs pertaining to the retina.
Here, we have primarily focused on the photoreceptors because of
their association with incurable blinding retinal diseases. Rod
photoreceptors, in particular, constitute nearly 80% of retinal neu-
rons in many mammalian species, including mouse and human
(Hendrickson et al., 2008; Lamb et al., 2007; Rapaport et al., 2004);
thus NGS data sets from retina are especially rich in rod
photoreceptor-related information. We envision the photorecep-
tors as an ideal paradigm for initiating multi-dimensional, system-
level studies that can be widely applicable to other cell types,
especially in the retina but broadly for the central nervous system.
2. Systems biology approaches
Biomedical research is mostly driven from phenotypic obser-
vations and curiosity to understand biological phenomena. For
example, forward genetic screening using animal models, such as
Drosophila melanogaster (fruit ﬂy), Caenorhabditis elegans and Mus
musculus (mouse), have led to identiﬁcation of many essential
genes and their function. Similarly, human genetic studies have
focused on identifying genes linked to speciﬁc phenotypes or traits,
thereby providing signiﬁcant insights into biological basis of the
disease. In addition, biochemical, genetic and molecular biology
approaches have further elucidated mechanism(s) of action of
speciﬁc molecules and cellular components. Though biological
pathways can be deciphered by compiling individual molecular
functions and binary relationships, current approaches are not
optimal in mapping complex regulatory interactions amongdiscrete constituents. Systems biology takes a bird's eye view of
cellular function with a goal of delineating molecular interactions
and crosstalk among the pathways (Ideker et al., 2001; Ryan et al.,
2013; Sorger, 2005), complementing the reductionist approach
(Fig. 1B). Although the concept of “systems biology” is not new
(Trewavas, 2006), it has had only limited success because of un-
availability of extensive data sets.
Recent advent of NGS and computational methodology has
permitted biologists to generate system-wide data sets, leading to
rapid advances in this ﬁeld. Three major components can be
assigned to systems biology, especially when we discuss GRNs
(Fig. 2A):
(i) Prediction of regulatory networks via generation of various
high throughput data sets and by computational analysis
(ii) Extension and/or reﬁnement of the networks by super-
imposing measurements made at multiple levels of cellular
constituents such as DNA, transcribed sequences, chromatin
state, proteins, and metabolites.
(iii) Assessment of system's response to time, risk factors or
interaction with its microenvironment (e.g., neighboring
cells/tissues)
A comprehensive system-level understanding of a cell/tissue/
organism requires integrated analysis of all intracellular molecular
interactions and pathways, including data sets from proteomic and
metabolomic studies. However, high throughput data from such
investigations is not readily obtainable for most tissues including
the retina (or other ocular cell types). We therefore limit our dis-
cussion to genetic and epigenetic control networks that can be
measured by NGS.
2.1. High throughput data generation
NGS is a versatile technology that can be coupledwith an endless
list of classical assay strategies (Table 1), enabling genome-wide
measurements of DNA sequence variations as well as components
of GRNs at both transcriptional and epigenetic levels. High
throughput genome-wide data generation requires a careful study
design, which can be summarized in two complementary strategies
(Fig. 2A). In the ﬁrst approach, the output is a nearly complete cat-
alog of components of a given class of biomolecules with relevant
quantitative information. For example, GRNs associated with rod
photoreceptors can be constructed by integrating a comprehensive
andquantitative catalogofmRNAtranscripts (usingRNA-seq), target
genes for key transcription factors (using chromatin
immunoprecipitation-sequencing, termed ChIP-seq), global proﬁles
of epigenome [histone modiﬁcations using ChIP-seq, and DNA
methylation using different NGS-based methods such as reduced
representation bisulﬁte sequencing (RRBS)], and other regulatory
molecules (such as miRNA, using small RNA-seq). In this review, we
will not discussNGS-basedmethods (summarized inTable 1),which
have been subjects of excellent reviews recently (Furey, 2012;
Metzker, 2010; Park, 2009; Telese et al., 2013; Wang et al., 2009).
With these data, regulatory networks can be inferred based on co-
expression and prior knowledge of interactions though additional
experiments areneeded for validation. In the second strategy, a ‘seed
network’ is employed for the experimental design. A known mo-
lecular interaction or functional hub is altered experimentally, and
the consequences of system perturbation are interrogated genome-
wide. For example, gene knock-out studies followed by mRNA or
epigenomic proﬁles would greatly assist in deciphering the associ-
atedGRN.While the former approach charts all the possible physical
or regulatory interactions, the latter reﬁnes the networks by directly
examining functional relationships.
Fig. 1. The mammalian retina and systems biology approaches. A, A representative retinal anatomy is shown by hematoxylin and eosin stained cross section of an adult mouse retina
(left) and by schematics (center and right). In the mammalian retina, six main neuronal classes are organized into three nuclear layers [outer nuclear layer (ONL), inner nuclear layer
(INL) and ganglion cell layer (GCL)] and form synaptic connections in two plexiform layers [outer plexiform layer (OPL) and inner plexiform layer (IPL)]. Cone and rod photoreceptors
comprise the outer retina with their cell bodies situated in ONL and their inner and outer segments (IS and OS, respectively) located between ONL and the retinal pigment epithelium
(RPE). RPE microvilli ensheath the outer segments, supporting phototransduction and photoreceptor survival. Photoreceptors transfer visual information through retinal in-
terneurons to ganglion cells. B, To date, population-based genetic analyses (i) and genetic and molecular studies of known genes (ii) have been major strategies in retinal research.
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Fig. 2. Strategies and aims of system-wide, multi-dimensional data analysis. A, Networks of a tissue or a cell type of interest can be inferred from high throughput data analysis.
Next generation sequencing (NGS) allows cataloging cellular constituents at a steady state and functional interactions when combined with system perturbation and differential
analysis. Molecular interactions are not conﬁned to only one molecular type such as DNA, transcripts, chromatin marks or proteins. Thus, multi-dimensional data integration further
reﬁnes the networks. In addition, comparative analysis is critical as discrete cells are subjected to temporal changes (i.e., development and aging) as well as interactions with
neighboring cells and the microenvironment, which evoke physiological modulation of the tissue and eventually of the organism. These holistic approaches will lead to new
discoveries of the biological systems and offer broad application. B, Cellular function is regulated at multiple levels. The DNA sequence contains the instructions of protein coding
and gene regulation, and diverse gene regulatory mechanisms ensure expression of a unique set of components highly specialized for each cell identity. Intrinsic and/or exogenous
damage to any level can lead to deleterious effects on function and survival of the system. TFact, transcription activator; TFrep, transcription repressor.
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Transcriptome analysis is central to comprehensive under-
standing of complex biological systems such as photoreceptors
(Swaroop and Zack, 2002). In RNA-seq assays, total RNA isolated
from a cell type or a tissue of interest is converted to cDNA and
deep-sequenced to obtain a comprehensive catalog of transcripts
(Mortazavi et al., 2008). Although mRNA-seq is most commonly
conducted, genome-wide proﬁling of regulatory RNAs is also
possible and provides an additional layer of information regardingSuch studies have long been a major driving force in identifying retinal disease genes and in
The “bottom up” approaches have been undertaken to build functional networks (iii) that ar
structural relationships among individual molecules. Considering widespread crosstalk betw
biomolecules is critical in constructing a comprehensive map of complex intermolecular
reductionist methodologies. The recent advent of next generation sequencing technologies
analysis of next generation sequencing and other types of high throughput data, ideally by int
well as homeostasis of tissues (vi), organs (vii), and organisms (i). RHO, rhodopsin; PDE, phgene regulation (Morin et al., 2008). RNA-seq offers many advan-
tages over hybridization-based expression proﬁling (such as
microarrays), permitting greater sensitivity and dynamic range in
transcript detection (Zhao et al., 2014) and more accurate identi-
ﬁcation of alternatively spliced transcripts (Shen et al., 2014). As
detection and quantiﬁcation of transcripts is not limited to the
current annotation, RNA-seq analysis enables discovery of novel
genes and of new transcripts from annotated genes (Wang et al.,
2009). Finally, RNA-seq can be performed even at the level of arevealing the function of the disease genes and their functional or structural associates.
e critical for retinal function (e.g., phototransduction pathway) by compiling functional/
een functional and/or regulatory networks (iv), system-wide measurement of various
regulatory interactions. Systems biology approach thus complements the traditional
has enabled system-level assessment of various biological processes. Computational
egratingmultiple data sets, allows a holistic approach to elucidate cellular function (v) as
osphodiesterase; CNG, cyclic nucleotide gated channel.
Table 1
High throughput techniques used in system-level data generation at multiple levels of biological pathways.
Method Information Strategy Reference
Genome WGS (whole genome sequencing) Genetic variation in the entire
genome
High throughput sequencing of the complete genome
WES (whole exome sequencing) Genetic variations in the exome Exome capture followed by high throughput sequencing. (Ng et al., 2009)
Repli-seq (replication sequencing) Temporal mapping of DNA
replication
BrdU labeling of newly replicated DNA and FACS-mediated fractionation of cell
populations according to cell cycle phases followed by high throughput sequencing.
(Hansen et al.,
2010)
ChIP-seq (chromatin immunoprecipitation
sequencing), ChIP-exo, or DamID
Genome-wide protein binding sites Genome-wide proﬁling of occupancy by a protein of interest. A speciﬁc antibody is
used to isolate protein-bound chromatin areas (ChIP-seq), and the resolution of the
assay can be further enhanced by employing exonuclease digestion of protein-
bound DNA ends (ChIP-exo). In cases that the speciﬁc ChIP quality antibody is not
available, the protein of interest that is fused to E. Coli DNA adenine
methyltransferase (Dam) and therefore methylates DNA adjacent to the binding
sites can be used instead.
(Barski et al., 2007),
(Rhee and Pugh,
2011)
Transcriptome RNA-seq Gene expression proﬁle Genome-wide proﬁling of transcripts. Typically, polyadenylated RNAs are enriched
for subsequent cDNA synthesis and high throughput sequencing.
(Mortazavi et al.,
2008)
small RNA-seq Regulatory RNA proﬁle Genome-wide proﬁling of small RNA species by high throughput sequencing with
modiﬁed cDNA synthesis protocols.
(Morin et al., 2008)
Deep CAGE (cap analysis of gene expression) Transcription start sites Capturing cDNA tags corresponding 50 ends of transcripts by cap trapping system
followed by high throughput sequencing.
(de Hoon and
Hayashizaki, 2008)
RNA-PET (RNA paired end tag) sequencing 50 and 30 ends of transcripts Proﬁling of 50 and 30 end tags of transcripts. This method is especially powerful in
detection of fusion transcripts.
(Ruan and Ruan,
2012)
GRO-seq (global run-on sequencing) Nascent transcripts Global mapping of transcriptionally active polymerase density by genome-wide
proﬁling of nascent RNA.
(Core et al., 2008)
Ribo-seq (ribosome proﬁling) Transcripts engaged with
translation
Proﬁling of ribosome-protected mRNA fragments by deep sequencing. (Ingolia et al., 2009)
CLIP-seq (Cross-linking immunoprecipitation
sequencing) or RIP-seq (RNA
immunoprecipitation sequencing)
Transcripts bound by a protein of
interest
High throughput sequencing of cDNA made from RNA pulled down with antibody
against a protein of interest. RNA-protein complexes are cross-liked with UV in
CLIP-seq. In RIP-seq, no cross-linking is necessary although formaldehyde-mediated
cross-linking can be included.
(Yeo et al., 2009)
(Zhao et al., 2010)
Epigenome &
chromatin
conformation
Histone modiﬁcation ChIP-seq Genome-wide map of histone
modiﬁcation
ChIP-seq can be also applied for genome-wide proﬁling of histonemodiﬁcations. For
histones, ChIP can be also performed without cross-linking of proteins to DNA
(native ChIP).
(Barski et al., 2007)
MeDIP-seq (methylated DNA
immunoprecipitation sequencing), WGBS
(whole genome bisulﬁte sequencing) or RRBS
(reduced representation bisulﬁte sequencing)
Genome-wide map of DNA
methylation
Genome-wide mapping of methylated cytosine (5 mC) of DNA. Methylated DNA can
be detected by various methods such as immunoprecipitation using 5 mC-speciﬁc
antibody (MeDIP-seq), MBD2b/MBD3L1 protein complexes with high afﬁnity to
5 mC (MIRA-seq) and sodium bisulﬁte conversion of unmethylated C to U (WGBS or
RRBS).
(Berman et al.,
2012; Gu et al.,
2011; Lister et al.,
2009; Weber et al.,
2005)
hMeDIP-seq (hydroxymethylated DNA
immunoprecipitation sequencing), TAB-seq
(Tet-assisted bisulﬁte sequencing)
Genome-wide map of DNA
hydroxy-methylation
Genome-wide mapping of hydroxymethylated cytosine (5 hmC) of DNA. 5 hmC is
either isolated by immunoprecipitation (hMeDIP-seq) or by glucosylation-mediated
protection of 5 hmC sites from the subsequent Tet enzyme assisted conversion of
5 hmC or MspI digestion (TAB-seq and RRHP-seq, respectively).
(Jin et al., 2011;
Song et al., 2011a;
Wu et al., 2011)
MNase-seq (micrococcal nuclease sequencing) Nucleosome positioning MNase digestion of chromatin followed by high throughput sequencing. MNase
preferentially cuts at the linker DNA between nucleosomes.
(Henikoff et al.,
2011)
4C-seq (circular chromosome conformation
capture sequencing) or HiC-seq
Chromatinechromatin interaction Variations of chromatin conformation capture (3C) assays to detect intra- or
interchromosomal interaction genome-wide. 4C-seq detects chromatin areas
interacting with one genomic locus of interest in genome-wide manner, whereas
HiC-seq captures all detectable chromatin-to-chromatin interactions.
(Lieberman-Aiden
et al., 2009; Rao
et al., 2014; Splinter
et al., 2012)
ChIA-PET (chromatin interaction analysis by
paired-end tag sequencing)
Chromatinechromatin interaction
mediated by a protein of interest
Chromatin immunoprecipitation and ligation of the adjacent DNA ends followed by
high throughput sequencing.
(Zhang et al., 2012)
DNase-seq (DNase I hypersensitivity
sequencing), FAIRE-seq (formaldehyde assisted
isolation of regulatory sequences), or ATAC-seq
(assay for transposase-accessible chromatin
sequencing)
Open chromatin Genome-wide mapping of open chromatin. Open chromatin can be selectively
isolated by the following characteristics: high sensitivity to DNase I digestion
(DNase-seq), segregation in aqueous phase upon phenol/chloroform extraction
(FAIRE-seq), or preferential transposon integration.
(Crawford et al.,
2006) (Giresi et al.,
2007)
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affordability, RNA-seq analysis is fast becoming a routine procedure
replacing microarrays.
2.1.2. Transcriptional and epigenetic regulation
Gene expression is controlled by combinatorial action of diverse
regulatory programs (Fig. 2B). Interaction of transcription factors
with speciﬁc cis-regulatory motifs is one of the primary mecha-
nisms underlying temporal and cell type-speciﬁc gene regulation.
ChIP, a widely used procedure to study transcription factor occu-
pancy in vivo (Gilmour and Lis, 1985; Weinmann and Farnham,
2002), can now be applied in conjunction with tiling array (ChIP-
on-chip) (Ren et al., 2000) or NGS (ChIP-seq) (Barski et al., 2007) to
examine genome-wide binding of a speciﬁc protein. NGS-based
methods (‘-seq’ assays) are now being used to delineate global
proﬁles of chromatin states (such as histone modiﬁcation, DNA
methylation, nucleosome positioning and chromatin accessibility)
and to identify novel fundamental mechanisms underlying gene
transcription (see Table 1).
2.1.3. DNA sequence variation
The human genome includes millions of sequence variations,
primarily in the non-coding regions; of these, tens of thousands
may be unique to an individual (Schaibley et al., 2013), and many
can even be linked to disease phenotype. Linkage analysis has
traditionally been successful in identifying the disease variant/gene
in monogenic RDDs, and genome-wide association studies (GWAS)
have identiﬁed variants associated with complex traits. More
recently, proﬁling of genetic variants using NGS methods, such as
whole exome sequencing (WES) and targeted or whole genome
sequencing (WGS), have transformed human genetic research. The
identiﬁed variants/mutations can provide valuable insights into
normal biology as well as elucidate mechanism(s) of disease
pathogenesis. For instance, gene ontology analysis of 142 genes
implicated in photoreceptor degeneration has identiﬁed a handful
of biological pathways including those associated with cilia
biogenesis, lipid metabolism, and phototransduction (Wright et al.,
2010). Similarly, genetic variants associated with susceptibility to
AMD have revealed the involvement of complement regulation,
cholesterol transport and extracellular matrix remodeling in dis-
ease pathogenesis (Fritsche et al., 2014).
2.2. Data integration
Once high throughput data is collected, computational tools are
employed to predict and construct GRNs. Although system-level
measurements are made at discrete levels such as transcriptome,
DNA-protein interaction, epigenome and genome, intermolecular
interactions that form a network are generally not conﬁned to a
single category. Thus, the experimental data pertaining to distinct
aspects of the network must be analyzed simultaneously and
assimilated to identify new patterns of a biological system, which
single data sets fail to detect.
Generation of networks by integrating multiple data sets ne-
cessitates that data are acquired under conditions of minimal
variability; e.g., from a single cell type since cellular heterogeneity
in the retina would create high transcriptional noise affecting the
generation of a viable and veriﬁable GRN across development and
disease states. Ideally, transcriptional and regulatory data for
network formation should be obtained from a speciﬁc cell type at
distinct stages of differentiation, aging or disease. Efforts have been
made to isolate individual neuronal cells of the retina for genome-
wide analysis. Such attempts, however, have been few and pri-
marily limited to gene expression proﬁling (Akimoto et al., 2006;
Siegert et al., 2012; Trimarchi et al., 2007). Table 2 lists publicdatabases containing high throughput data relevant to studies of
the retina.
2.3. System comparison
Biological systems are highly dynamic and undergo progressive
transition over time (Hwang et al., 2012). During development,
intrinsic and extrinsic factors sequentially restrict cell fates and
specify morphology and function most suited for a given cellular
identity. Cumulative adaptive responses to internal and/or envi-
ronmental challenges over a lifespan also impact spatio-temporal
architecture of a system. Therefore, comparisons along time se-
ries data sets represent valuable strategies to assess system dy-
namics. Additionally, continuous ﬂuctuations imposed by
microenvironment and/or intrinsic genetic variations may induce
changes beyond the cell tolerance level and manifest as a disease.
The use of animal models for retinal traits or diseases provides a
powerful tool to evaluate direct inﬂuence of genetic mutation(s) or
experimental stress on networks as relatively little variation is
expected in congenic strains raised under uniform conditions.
Another important factor in system dynamics is variability among
cell types exhibiting functional interaction such as between pho-
toreceptors and retinal pigment epithelium (RPE); for example,
defects in RPE are associated with photoreceptor dysfunction or
death (Strauss, 2005). Even cells of the same neuronal type may
display high variability based on temporal context and spatial or-
ganization (Trimarchi et al., 2007).
Change in system architecture can be ascertained from human
population genetics using control individuals and patients with a
speciﬁc disease/trait (e.g., AMD). Such genetic association studies
exploit naturally occurring differences that cannot necessarily be
generated by experimental means. However, it should be noted that
the strength of data sets depends on the size of the cohort and
penetrance of a speciﬁc variant/mutation. Elucidation of multifac-
torial complex biological phenomena, such as aging and patho-
genesis of complex disease, can especially beneﬁt from
comparative system-level analysis using large NGS-based genomic
data.
In the following sections, we will elaborate on system-level
analysis of rod photoreceptors in three disciplines: development
(Section 3), aging (Section 4) and degenerative disease (Section 5).
3. System-level analysis of retinal photoreceptor
development
Early attempts for system-wide assessment of photoreceptor
development included gene expression proﬁling of the retina using
expressed sequence tags (ESTs), serial analysis of gene expression
(SAGE) and microarrays (Fig. 3A) (Akimoto et al., 2006; Blackshaw
et al., 2001; Gieser and Swaroop, 1992; Livesey et al., 2000; Sharon
et al., 2002; Yoshida et al., 2004; Yu et al., 2003b). NGS-based
methods have dramatically expedited the pace of expression
proﬁling and permitted the application of gene regulation assays to
genome-wide scale (Fig. 3B). In addition to examining the whole
retina, we can now develop quantitatively precise expression pro-
ﬁles of individual cell types and obtain global data on transcription
factor binding and epigenomic marks. Multi-dimensional data
integration should therefore enable us to identify novel patterns in
GRNs that control functional architecture of individual retinal cells,
such as photoreceptors.
In the developing vertebrate retina, rod and cone photorecep-
tors differentiate from common pools of retinal progenitor cells
with distinct temporal proﬁles. While cone generation ceases
prenatally in rodents, rod birth spans a long time window from
embryonic day (E)12 to postnatal day (P)10 with peak at P0eP2
Table 2
Public databases containing clinical or high throughput retina data sets.
Database URL Description Reference
Allen Brain Atlas http://www.brain-map.org/ Public resources integrating comprehensive gene expression
and anatomical data from developing or adult mouse and
human brain
(Hawrylycz et al., 2012;
Lein et al., 2007)
BrainCloud http://braincloud.jhmi.edu/
plots/
Database of temporal gene expression dynamics in the human
prefrontal cortex across the lifespan
(Colantuoni et al., 2011)
EyeSAGE http://neibank.nei.nih.gov/
EyeSAGE/index.shtml
Resource for retina, RPE and trabecular meshwork
transcriptomes
(Bowes Rickman et al.,
2006)
Gene Expression Omnibus (GEO) http://ncbi.nlm.nih.gov/geo Public data repository of functional genomics data supporting
MIAME-compliant data submissions
Gene Expression Proﬁle Database http://www.fmi.ch/roska.data/
index.php
Microarray data across diverse adult mouse retinal cell types (Siegert et al., 2012)
High resolution fundus
image database
https://www5.cs.fau.de/
research/data/fundus-images/
Database of fundus images of healthy eyes and eyes with
diabetic retinopathy or glaucoma
Human Retinal Transcriptome http://oculargenomics.meei.
harvard.edu/index.php/ret-
trans
The human retina transcriptome data generated from three
normal human retinas using RNA-seq
(Farkas et al., 2013)
mirNEYE http://mirneye.tigem.it Expression atlas of 221 miRNAs in the developing and adult
wild type mouse eye
Mouse Retina SAGE library http://cepko.med.harvard.edu Database of gene expression proﬁling of developing and adult
mouse retina and a few other non-ocular tissues. In situ
hybridization data are also available for select genes.
(Blackshaw et al., 2001;
Blackshaw et al., 2004)
NEIbank http://neibank.nei.nih.gov/
index.shtml
Database of assembled EST data from ocular tissues of various
organisms
Retina Central (WEBER) http://www.retinacentral.org/ Database of genes experimentally shown to be expressed in the
retina/the retinal pigment epithelium.
(Schulz et al., 2004)
Retina International http://www.retina-
international.org/sci-news/
databases/mutation-database/
Database of retinal diseases, mutations, animal models and
disease-associated proteins
Retinal Express http://odin.mdacc.tmc.edu/
RetinalExpress/
E14.5 mouse retina cDNA/EST database
RetinoBase http://alnitak.u-strasbg.fr/
RetinoBase/
Microarray database generated from all publicly available
retina-related gene expression proﬁles
(Kalathur et al., 2008)
RetNet (Retinal information
network)
https://sph.uth.edu/retnet/ Database of genes and loci causing inherited retinal diseases
RP Gene Expression Atlas http://rpexp.tigem.it/ Collection of in situ hybridization data for retinitis pigmentosa
genes in mouse and human retina
STARE (Structured analysis
of retina)
http://www.ces.clemson.edu/
~ahoover/stare/
Database of retinal images of various clinical manifestations (Hoover and Goldbaum,
2003; Hoover et al.,
1998)
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ceptor identity is largely dictated by an intrinsic transcriptional
program (Swaroop et al., 2010) that involves a number of tran-
scription factors, including cone-rod homeobox protein CRX (Chen
et al., 1997; Furukawa et al., 1997), neural retina leucine zipper
protein NRL (Mears et al., 2001; Swaroop et al., 1992) and thyroid
hormone receptor THRB (also called TRb2) (Ng et al., 2001). CRX
plays an essential role in photoreceptor development (Furukawa
et al., 1999) by controlling the expression of both rod and cone
genes (Corbo et al., 2010; Hennig et al., 2008). NRL and THRB,
however, determine the genesis of rods (Mears et al., 2001) and
medium wavelength sensitive (M) cones (Ng et al., 2011), respec-
tively, from photoreceptor precursors that seem to be otherwise
speciﬁed by “default” as short wavelength sensitive (S) cones
(Swaroop et al., 2010). Other essential regulators of photoreceptor
development include OTX2 (Nishida et al., 2003; Roger et al., 2014),
RORB (Jia et al., 2009; Srinivas et al., 2006) and NR2E3 (Chen et al.,
2005; Cheng et al., 2006, 2011; Haider et al., 2000; Oh et al., 2008;
Peng et al., 2005). These key transcriptional regulators constitute
central nodes (“hubs”) in the GRN that controls photoreceptor
development.
3.1. Cell type-speciﬁc approaches for generating GRN
Although few studies have been performed using puriﬁed
photoreceptor cells, rod photoreceptor-speciﬁc information can be
predicted by genome-wide data generated from the predominantly
rod-containing mouse or human retina. Considering that NRL andCRX expression are largely photoreceptor-speciﬁc, ChIP-seq data
for these two key transcription factors would broadly reﬂect
photoreceptor biology. The same is not true for transcriptome and
epigenome data obtained from the whole retina. Isolation of pho-
toreceptors is necessary to acquire true photoreceptor-speciﬁc in-
formation. Cell type-speciﬁc approaches are even more critical for
developmental studies since the proportion of photoreceptors in
mouse retina continuously increases until P10, making it difﬁcult to
discern true cellular changes in gene expression or epigenetic
marks. The ﬁrst example demonstrating the importance of cell
type-speciﬁc studies comes from microarray-based expression
proﬁling of ﬂow-sorted rod photoreceptors from Nrlp-GFP mice
(Akimoto et al., 2006). The resulting rod-speciﬁc transcriptome
data effectively detected many low level transcripts that had not
been observed in the whole retina transcriptome data. Although
many transgenic mouse lines expressing ﬂuorescence reporters in
speciﬁc retinal cell types have been described and are being used
for transcriptome analysis (Siegert et al., 2012), identiﬁcation of
new cell type-speciﬁc markers (Koso et al., 2009) would greatly
facilitate NGS studies of retinal neuronal subtypes.
An array of subtypes, each with uniquemorphology and function,
can be recognized within major classes of retinal neurons (Masland,
2012). Single cell gene expression proﬁling has demonstrated a high
degree of heterogeneity among individual retinal cells (Trimarchi
et al., 2008). A better understanding of biological events thus re-
quires delineation of GRNs speciﬁc not only at the level of individual
subtypes but perhaps even at a single cell level. Due to limitations in
obtaining sufﬁcient material, conventional methods need to be
Fig. 3. Timeline of genome-wide studies of the retina biology and disease pathogenesis. The advent of genome-scale proﬁling technologies has been a critical step for systems
biology approaches. A, From the pioneering high throughput transcript analysis, such as the initial application of microarray and serial analysis of gene expression (SAGE), to whole
genome sequencing, an ever-growing number of genome-wide studies have advanced our knowledge about healthy retina and disease pathogenesis. Highlights of such innovative
genome-scale studies were selected and presented chronologically. B, For more than a decade, microarray has been a widely used methodology of choice for gene expression
proﬁling, yielding a substantial number of publications each year. RNA-seq, deep sequencing of cDNA using NGS technology, is becoming more accessible and affordable and thus
expected to be applied more widely. In addition to transcriptome analysis, NGS is applicable to a variety of other conventional research techniques and has already generated
numerous data sets surveying whole exomes for genetic variation (whole exome sequencing), transcription factor targetome (ChIP-seq) and epigenome (ChIP-seq for histone
modiﬁcations and various DNA methylome sequencing methodologies). 1(Livesey et al., 2000), 2(Blackshaw et al., 2001), 3(Mu et al., 2001), 4(Yoshida et al., 2002), 5(Sharon et al.,
2002), 6(Farjo et al., 2002), 7(Chowers et al., 2003b), 8(Gustincich et al., 2004), 9(Klein et al., 2005), 10(Akimoto et al., 2006), 11(Trimarchi et al., 2007), 12(Arora et al., 2010; Hackler
et al., 2010; Karali et al., 2010; Wang et al., 2010), 13(Chen et al., 2010b), 14(Neale et al., 2010), 15(Otto et al., 2010), 16(Tummala et al., 2010), 17(Corbo et al., 2010), 18(Grant et al., 2011),
19(Brooks et al., 2011; Mustaﬁ et al., 2011), 20(Popova et al., 2012), 21(Hao et al., 2012), 22(Farkas et al., 2013), 23(Oliver et al., 2013b), 24(Fritsche et al., 2013), 25(Nishiguchi et al., 2013),
a number of publications until September 2014.
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However, technical hurdles including sample loss, degradation and
contamination can have more pronounced impact on quality and
robustness of data generated from single cells or small quantities
versus large pools of cells. In addition, many rounds of PCR ampli-
ﬁcation may generate increased noise and inaccurate quantiﬁcation.
Nevertheless, cell type-speciﬁc or even single cell level analyses are
necessary to extract gene regulatory information relevant to the cell
of interest. Single cell collection methods based on micro-ﬂuidic
systems (Shalek et al., 2014), high-resolution imaging (Lubeck and
Cai, 2012), and better protocols for constructing NGS libraries from
small amount of starting RNA (Brooks et al., 2012; Tang et al., 2009;
Tariq et al., 2011) have made it possible to attempt more robust
expression proﬁling of individual retinal neurons. However, a major
challenge remains for the generation of epigenomic and other NGS
data sets with small number of cells. Our laboratory and others are
currently developing such protocols (Adli et al., 2010; Guo et al.,
2013; Smallwood et al., 2014).The importance of using a puriﬁed single cell type for system-
level analysis cannot be over-emphasized since biological pro-
cesses such as development and aging have broad and concurrent
impact on multiple cell types in a tissue and on the organism as a
whole. Deciphering photoreceptor GRN from the whole retina
studies would be complicated by transcriptional noise and differ-
ences in epigenome and regulatory molecules among different cell
types. This is especially true for dissecting changes in GRNs during
the pathogenesis of photoreceptor degeneration. As photoreceptor-
speciﬁc data are not available for all NGS-based assays, we also
cover studies from the whole retina in the discussion below.
3.2. Construction of photoreceptor GRN
Gene expression requires context-speciﬁc interaction among
cis-regulatory DNA elements, basal transcriptional machinery and
transcription regulatory proteins. In addition, transcriptional ac-
tivity is under the inﬂuence of chromatin architecture as well as
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photoreceptor GRN include:
(i) Global mRNA proﬁling by RNA-seq (Section 3.2.1)
(ii) Identiﬁcation of target genes for cell speciﬁc transcription
factors by ChIP-seq (Sections 3.2.2 and 3.2.3)
(iii) Chromatin state such as histone modiﬁcations by ChIP-seq,
DNA methylation proﬁling, and chromatin accessibility by
DNase I hypersensitivity sequencing (Section 3.2.4)
(iv) Regulatory RNA proﬁling (Section 3.2.5)
Transcriptional proﬁles are also needed at multiple stages of rod
development in order to build a developmental GRN. Gene
expression proﬁling can be used in conjunction with gain- or loss-
of function mutations of relevant “hub” transcription factors to
further validate GRNs. For example, known hubs in the photore-
ceptor network such as NRL and CRX can be perturbed (e.g., in
mouse mutants) before genome-wide gene expression analysis.
The genes showing altered expression in the absence of a regula-
tory factor would represent direct or indirect (i.e., through sec-
ondary regulatory nodes) transcriptional targets. Additionally, GRN
can also be inferred from co-expression data. Groups of genes that
share similar expression signatures in response to experimental
manipulation and/or during development would likely represent
common gene regulatory pathways. Although such information is
only suggestive, co-expression data allow for the identiﬁcation of
novel testable regulatory patterns.
3.2.1. Expression proﬁling
Global proﬁling of gene expression in the developing and mature
retina was ﬁrst accomplished by Affymetrix™ microarrays (Dorrell
et al., 2004; Yoshida et al., 2004). Expression proﬁles have also
been generated from ﬂow-sorted rod photoreceptors (Akimoto et al.,
2006; Parapuram et al., 2010) and from single retinal cells (Ma et al.,
2013; Roesch et al., 2008; Trimarchi et al., 2007; Xue et al., 2011).
However, NGS-based RNA-seq proﬁling has yielded more quantita-
tively precise information on mRNA transcripts in the mammalian
retina (Brooks et al., 2011; Farkas et al., 2013; Gamsiz et al., 2012;
Kandpal et al., 2012; Kozhevnikova et al., 2013; Roger et al., 2014).
More recently, we have produced extensive RNA-seq-based temporal
expression proﬁles of puriﬁed rod photoreceptors that reveal novel
insights in cellular pathways (Fig. 4A) (Kim et al., manuscript
in preparation) as well as additional modes of gene regulation,
such as alternative splicing (Fig. 4B).
3.2.1.1. Perturbation studies. For elucidating GRNs, it is valuable to
generate gene proﬁles after disrupting one of the key regulatory
nodes. This strategy was ﬁrst applied to Crx/ mice (Blackshaw
et al., 2001; Hennig et al., 2008; Livesey et al., 2000). CRX is essen-
tial for both cone and rod development (Furukawa et al., 1999);
however, its role in cell fate determination is debatable because of
overlapping functions with another homeodomain protein OTX2,
which regulates the expression of CRX as well as NRL (Nishida et al.,
2003; Omori et al., 2011; Roger et al., 2014; Terrell et al., 2012). A
majority of genes with altered expression in Crx/ mice showed
photoreceptor enriched expression, and functional categorization of
differentially expressed genes has revealed an array of CRX-regulated
cellular functions, including those involved in phototransduction,
metabolism, signal transduction and cytoskeletal components.
Another extensively studied gene regulatory program is the
NRL-centered transcriptional network. The ﬁrst observation that
NRL is the master switch for generating rod cell fate came from
studies of Nrl/ mice as their retina completely lacks rod photo-
receptors, with concurrent enhancement of S cone function (Mears
et al., 2001). In concordance, ectopic expression of NRL inphotoreceptor precursors or in early-born S-cones resulted in for-
mation of functional rods (Oh et al., 2007). Gene proﬁling of Nrl/
retina revealed little or no expression of rod-speciﬁc genes,
including those associated with rod phototransduction, and a
concomitant increase in the expression of S cone photopigment
(encoded by Opn1sw) and other cone genes (Brooks et al., 2011;
Yoshida et al., 2004; Yu et al., 2004a). Global expression analysis
of puriﬁed photoreceptors from Nrl/ retina has validated the
essential role of NRL in activating the expression of rod genes and
suppressing cone genes (Akimoto et al., 2006).
NR2E3, an orphan nuclear receptor, constitutes another impor-
tant hub in photoreceptor GRN and is a direct transcriptional target
of NRL (Bumsted O'Brien et al., 2004; Oh et al., 2008). Mutations in
NR2E3 cause enhanced S cone syndrome in humans (Haider et al.,
2000; Sharon et al., 2003; Wright et al., 2004), similar to the
retinal phenotype exhibited by Nrl/ mice (Mears et al., 2001).
Retinal and rod gene expression proﬁling of rd7 mutant mice, in
which Nr2e3 function is ablated, further validates NR2E3 function
primarily as a suppressor of cone genes and as a co-activator (with
NRL and CRX) of rod genes (Chen et al., 2005; Cheng et al., 2006,
2011, 2004; Corbo and Cepko, 2005; Haider et al., 2009; Oh et al.,
2008; Peng et al., 2005).
3.2.1.2. Co-expression network analysis. Target genes of the a tran-
scriptional regulator likely display similar expression patterns and
may participate in common or related cellular functions (Yu et al.,
2003a). Clusters of co-expressed genes can thus be used to model
gene regulatory events. The inferred GRNs enable the detection of
putative protein-DNA and proteineprotein interactions without
requirement of prior knowledge. Mathematical tools have been
developed to predict GRNs from gene expression proﬁle data, and
putative regulatory relationships can then be validated experi-
mentally (Hecker et al., 2009). Co-expression network inference
thus represents a powerful analytical tool for expression proﬁling
data, complementing the perturbation studies discussed above. As
activity of a given transcriptional regulator is conﬁned only to the
same cell as its target, only the information obtained from a single
cell or cell type provides accurate prediction without analytical
noise caused by sample heterogeneity. Transcriptome analysis of
ﬂow-sorted rod photoreceptors from wild type and Nrl/ retina
has revealed multiple clusters of co-expressed genes, which likely
represent diverse regulatory events (Akimoto et al., 2006). Co-
expression analysis of newer and deeper RNA-seq data sets
should provide valuable insights, including those relevant for
identiﬁcation of disease genes and pathways (see also Section 5.4).
3.2.2. Transcription targets (“targetome”) of NRL and CRX
Differential gene expression analysis does not distinguish direct
transcriptional regulation from secondary regulatory events. ChIP-
seq analysis, on the other hand, assays direct physical interactions
between a transcription factor and the cognate DNA elements.
Recent studies have superimposed transcriptome and transcription
factor targetome data to identify biologically relevant target genes
of CRX (Corbo et al., 2010) and NRL (Hao et al., 2012). ChIP-seq
analysis of mouse retina demonstrated CRX binding to 67% of
mis-regulated genes in Crx/ retina, likely representing direct CRX
targets (Corbo et al., 2010). Similarly, only a subgroup (15%) of genes
differentially expressed in Nrl/ retina exhibited NRL ChIP-seq
peaks and thus are direct transcriptional targets of NRL (Hao
et al., 2012).
One of the challenges in deciphering targetome data is assigning
transcription factor binding to relevant genes. A majority of NRL-
and CRX-bound genomic DNA regions are in close proximity of or
within the genes. However, binding of regulatory factors far away
from genes is not uncommon and may exert transcriptional control
Fig. 4. Cell type-speciﬁc System-level analysis. A, Heat map of time course RNA-seq data generated from isolated, developing (P2 to P14) and mature (P28) mouse rod photore-
ceptors. Dynamic gene regulation during rod photoreceptor maturation and clusters of genes with similar temporal expression patterns are apparent. Heat map was generated
based on log2FPKM, and individual co-expression clusters were highlighted with different colors in the dendogram. FPKM, fragments per kilobase of exon per million reads. B,
Transcript-level analysis of RNA-seq data enables detection of complex gene regulatory programs such as distinct splicing events during development. Alternative splicing of Bsg
(basigin) gene during rod photoreceptor development is shown as an example. Coverage plots (dark gray histogram) and read alignments (gray blocks indicating individual
sequence reads with thin blue horizontal lines connecting portions of sequence reads that are split between exons) show differential inclusion of the second exon (brown shade) in
P2 and P28 rod photoreceptors. Expression level of each splice variant during rod development is plotted and shown on the right. C, System-level proﬁling of diverse chromatin
signatures, including chromatin accessibility [DNase-seq (DNase I hypersensitivity sequencing)], active and repressive promoter histone modiﬁcations (H3K4me3 and H3K27me3,
respectively; mini-ChIP-seq) and DNA methylation (bisulﬁte sequencing). Application of genome-wide analysis of chromatin states used to be limited to in vitro samples and pooled
tissues of heterogeneous cell types. Bisulﬁte sequencing and ChIP-seq have now been miniaturized for ﬂow-sorted single type of neurons, which are available in small amounts.
Shown are active gene expression and hallmark of active chromatin state of two select photoreceptor-speciﬁc genes, Crx and Slc24a1, in P28 ﬂow-sorted rod photoreceptors. Scale on
y-axis of RNA, DNase, K4me3 and K27me3 tracks indicates RPM (reads per million reads). Average percent 5-methylcytosine (meDNA) within promoter (±1 kb from the tran-
scription start site, highlighted with a gray shade) was plotted as a bar graph.
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assays have successfully validated the enhancer activity of over
1000 CRX interacting genomic loci (White et al., 2013). Similar
large-scale enhancer assays and chromatin state mapping are ex-
pected to conﬁrm the functional signiﬁcance of distant ChIP-seq
peaks. Integrated analysis with gene expression data and long
distance chromatin association proﬁling [by chromatin conforma-
tion capture (3C) assay (Peng and Chen, 2011) and its NGS appli-
cations such as 4C-seq and HiC-seq] (see Table 1) will further
facilitate the identiﬁcation of novel transcription targets of key
photoreceptor transcription factors.
ChIP-seq analyses have identiﬁed thousands of genomic loci
(sequence regions) that are occupied by NRL or CRX in vivo, andboth transcription factors bind to common enhancer regions that
specify photoreceptor genes (Hao et al., 2012). In embryonic stem
cells (ESCs), master transcriptional regulators are reported to form
super-enhancers, atypical long enhancer clusters that are associ-
ated with unusually high level of mediators as well as enhancer-
associated epigenetic marks (Whyte et al., 2013). Subsequent
studies have demonstrated the importance of super-enhancers in
many differentiated cell types (Hnisz et al., 2013) and their impli-
cations in developmental and neurological disease (Lee and Young,
2013). Further investigations are necessary to evaluate whether
NRL- and CRX-bound enhancer elements exhibit characteristics of
super-enhancers and whether variants in these elements are
associated with retinal disease.
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Most of the transcription factor targetome analyses have so far
been conducted at a single time point, revealing only a snapshot of
gene regulation. The function of transcriptional regulators, how-
ever, is highly dynamic (Davidson and Levine, 2008; Hwang et al.,
2012). Transcriptional complexes are under continuous modula-
tion by availability of co-factors and by chemical modiﬁcations at
the level of protein, DNA and/or chromatin (Berger, 2007; Voss and
Hager, 2014). Thus, the regulatory outcome can vary depending on
cellular context such as developmental stage, cell identity and
ﬁtness. Comparative transcriptome analysis of the retina and of
ﬂow-sorted rod photoreceptors across developmental stages has
revealed a striking variation in expression kinetics among photo-
receptor genes controlled by NRL (Akimoto et al., 2006; Yoshida
et al., 2004; Yu et al., 2004a). Nrl expression is initiated immedi-
ately after the ﬁnal mitosis of photoreceptor precursors, leading to
expression of a large number of target genes including Nr2e3.
Notably, a number of NRL target genes, including visual pigment
rhodopsin (encoded by Rho), exhibit substantial delay in expression
during rod photoreceptor development.
Although underlying factors for differential onset of expression
of NRL target genes are not completely understood, analyses of
multiple data sets suggest additional control mechanisms. One of
the possible scenarios can be inferred by linking NRL targetome
data with gene expression proﬁles and with previously identiﬁed
retinal disease loci (Hao et al., 2012). NRL target genes with putative
functional relevance can be selected based on the assumption that
such genes are likely associated with rod function and cause retinal
degeneration when mutated. Such analyses have identiﬁed histone
demethylase KDM5B as a secondary regulatory node, and Kdm5b
knock-down partially phenocopies the rod-to-cone transition
observed in Nrl/ retina (Hao et al., 2012). KDM5B is one of the
histone demethylases implicated in gene repression through
demethylation of H3 lysine 4 trimethylation (H3K4me3), a histone
mark associated with transcriptional activation. Thus, it can be
hypothesized that NRL function is mediated throughmultiple as yet
unidentiﬁed secondary nodes (including epigenetic factors) and
that other regulatory mechanisms may deﬁne precise temporal
control of gene expression. Functional interaction between NRL-
centered transcriptional network(s) and the epigenetic program
will be further elaborated in the following section 3.2.4.
Another important feature of GRNs is combinatorial actions of
transcriptional regulators (Davidson and Levine, 2008). Numerous
pre-genomic approaches have reported cooperative functions
among photoreceptor transcription factors. Interaction between
NRL and CRX exerts synergistic effects on transcriptional activation
of rod-speciﬁc genes (Mitton et al., 2000; Pittler et al., 2004;
Yoshida et al., 2004). As part of the same complex, NR2E3 ex-
hibits dual function by inducing rod and suppressing cone gene
expression (Oh et al., 2008; Webber et al., 2008), thereby consti-
tuting a critical secondary transcriptional regulatory node (Chen
et al., 2005; Cheng et al., 2006, 2004; Haider et al., 2000; Peng
et al., 2005). Compiling system-wide surveys of putative target
genes for these three regulators has revealed signiﬁcant overlaps in
their targets (Hao et al., 2012; Qian et al., 2005; Yu et al., 2006),
suggesting that combinatorial functions among transcription fac-
tors exert tight regulation of photoreceptor development and ho-
meostasis. Salient features of NRL transcriptional regulatory
network have been assembled (Hao et al., 2012), and further
computational analyses of existing and new data sets are expected
to provide a comprehensive map of rod photoreceptor GRNs
(Hwang et al., 2012; Wan et al., 2013).
Combinatorial action of regulatory factors is highly context-
dependent and cell type-speciﬁc, and the composition of tran-
scriptional complexes is expected to inﬂuence the selectivity ofdownstream target genes. For instance, although CRX expression is
common to both rods and cones, transcriptional regulatory out-
comes show a striking difference. CRX cooperates with RORB to
induce S cone photopigment (Opn1sw) expression in cone pre-
cursors (Srinivas et al., 2006), whereas, in the presence of NRL and
NR2E3, CRX enhances rod-speciﬁc gene expression in rod photo-
receptors (Hao et al., 2012). ChIP-seq analysis has shown that
OTX2-bound cis-regulatory elements are quite different in RPE and
neural retina (Samuel et al., 2014). Only retina-speciﬁc OTX2 target
sites, but not RPE-speciﬁc ones, show redundancy with CRX occu-
pancy, further demonstrating the importance of combinatorial
transcriptional programs in cell fate speciﬁcation.3.2.4. Chromatin state and gene regulation
DNA within a cell is packaged into DNA-protein complexes
(termed chromatin), which constitute a dynamic structure. DNA
itself and the histones, which are primary protein components in
the chromatin, are subjected to chemical alterations that can in-
ﬂuence transcriptional activity. Regulation of chromatin state is an
important mechanism for modulating biological states, including
lineage restriction and cell fate speciﬁcation during development
(Hirabayashi and Gotoh, 2010; Meshorer and Misteli, 2006; Sasaki
and Matsui, 2008; Wan et al., 2013). Studies of epigenetic marks
such as DNA methylation and posttranslational modiﬁcations of
histones in the retina have revealed cell type- and stage-speciﬁc
chromatin states, recapitulating context-dependent differential
gene regulation.3.2.4.1. DNA methylation. DNA methylation at gene promoters has
been negatively associated with gene expression and is considered
a key mechanism for maintenance of chromatin state (Suzuki and
Bird, 2008). Integration of global DNA methylation proﬁles with
gene expression is critical for deciphering the overall structure of a
GRN. System-level analysis of DNA methylome has implicated dif-
ferential 5-methylcytosine in altering gene expression during
photoreceptor degeneration in rd1 retina (Farinelli et al., 2014) as
well as in tissue-speciﬁc splicing in the retina and the brain (Wan
et al., 2013). More restricted approaches examining selected
genes further support the association of DNA methylation with
photoreceptor gene regulation. Bisulﬁte sequencing of targeted
genomic areas from WERI and Y9 human retinoblastoma cell lines
and laser-capture micro-dissected mouse photoreceptors and non-
photoreceptor cell types has revealed photoreceptor-speciﬁc cyto-
sine hypomethylation within opsin genes such as Rho, Opn1sw and
Opn1mw (Merbs et al., 2012), demonstrating cell type-speciﬁc
patterns of DNA methylation. Conditional knock-out of DNA
methyltransferase 1 (Dnmt1) shows lack of outer segments despite
nearly normal expression of phototransduction and cilia genes in
photoreceptors (Nasonkin et al., 2013), suggesting a broad impact
of DNA methylation on morphological speciﬁcation.
Contrary to rapidly growing number of gene expression
proﬁling studies, only few genome-wide DNA methylome
proﬁles have been generated for the retina (Fig. 3B). New highly
sensitive detection assays for 5-methylcytosine and 5-
hydroxymethylcytosine (see Table 1) (Oliver et al., 2013b;
Smallwood et al., 2014) and with single cell-type resolution
(Powell et al., 2013) are expected to facilitate such investigations at
the level of a single retinal neuron. We have recently completed the
generation of DNA methylome for ﬂow-sorted rod photoreceptors
and are examining its relationship to RNA-seq and histone modi-
ﬁcation data sets (Fig. 4C) (Yang et al., manuscript in preparation).
Further technical improvements should therefore unravel system-
wide interactions between DNA methylation and cell type-
speciﬁc dynamics of gene expression.
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on different histones undergo diverse posttranslational modiﬁca-
tions including acetylation and methylation (Kouzarides, 2007;
Zentner and Henikoff, 2013). While histone acetylation is almost
strictly associated with active gene expression, methylation rep-
resents more complex modes in gene regulation. Transcriptional
activity is shown to depend on the degree of methylation emono-,
di-, and trimethylation, the speciﬁc modiﬁed amino acid residue
and associated DNA elements (e.g., promoter, gene body, en-
hancers). Among multitudes of reported histone methylations,
H3K4 and H3K27 methylation are closely correlated with tran-
scription status and thus constitute the most commonly examined
histone modiﬁcations. Promoters of active and silent genes are
enriched with H3K4me2/me3 and H3K27me3, respectively, while
active and repressive enhancers are demarcated with H3K4me1/
H3K27ac and H3K4me1/H3K27me3, respectively. Dynamic regu-
lation of histone methylation patterns in rod or cone photorecep-
tors is expected to have signiﬁcant impact on photoreceptor GRNs.
ChIP-seq is fast becoming a routine procedure for genome-wide
proﬁling of histone modiﬁcations. Histone signature, however, is
highly heterogeneous across distinct cell types (ENCODE Project
Consortium, 2012); thus, cell type-speciﬁc histone modiﬁcation
proﬁling is necessary to obtain useful information on the chromatin
state. Puriﬁed cells do not easily meet the requirement of sample
size for reported epigenome proﬁling assays as yet.
The whole retina histone ChIP-seq performed with appropriate
control tissue such as rd1 mutant retina, a degenerative mouse
model that lacks photoreceptors, has offered signiﬁcant
photoreceptor-speciﬁc epigenomic information as rod photore-
ceptors account for a vast majority of retinal neurons in mature
retina (Popova et al., 2012). In this study, genome-wide signatures
of H3K4me2 and H3K27me3 in the mouse retina were mapped
and compared with transcriptome at various developmental
stages. Distinct clusters of chromatin modiﬁcation dynamics were
identiﬁed among rod-speciﬁc genes (Popova et al., 2012). Sur-
prisingly, rod genes showed varied H3K4me2 signature. While
some rod genes have a detectable level of H3K4me2 as early as
E17.5 and at all subsequent developmental stages, another group
of rod genes including phototransduction genes shows delayed de
novo accumulation of H3K4me2 from P7 to P15. Concordantly,
phototransduction genes gain full chromatin accessibility only
after P10 as revealed by DNase I hypersensitivity sequencing
(DNase-seq) of the mouse retina (ENCODE, www.mouseencode.
org). ChIP experiments have demonstrated a limited interaction
of NRL with cognate DNA binding site in Rho at P2 (Hao et al.,
2011), suggesting that inactive chromatin state at Rho and other
phototransduction genes may interfere with NRL binding to its
target genes in newborn rods. These results, however, should be
interpreted with caution as the detected change in histone marks,
chromatin accessibility and NRL recruitment may simply reﬂect a
dramatic increase in the proportion of rod photoreceptors in the
retina from P2 to P28. Assays using puriﬁed rod photoreceptors
offer an ideal alternative. Our initial analysis of histone ChIP-seq
data from puriﬁed rod photoreceptors has revealed promising
insights into rod-speciﬁc histone signature (Fig. 4C) (Yang et al.,
manuscript in preparation).
3.2.5. miRNA and other transcribed sequences
Non-coding RNAs (ncRNAs) constitute as much as 80% of the
human transcriptome (Rosenbloom et al., 2013) and contribute
additional complexity to GRNs (reviewed in Mortimer et al., 2014).
Small ncRNAs (<200 bp) include microRNAs (miRNAs) of 18e24
nucleotides. Long ncRNAs (lncRNAs) are over 200 bp in length but
can be up to hundreds of kb. Each of the reported 2000e3000
miRNAs (miRBASE Release 21, June 2014) can regulate hundreds oftarget genes, and each mRNA can be targeted by several miRNAs,
ﬁne tuning gene expression of an estimated 30e80% of the human
genome (John et al., 2004; Lim et al., 2005; Lu and Clark, 2012). Tens
of thousands of lncRNAs are expressed at low levels in a tissue-
restricted manner and believed to regulate the expression of
related genes associated with most biological processes in a given
cell (Li and Chang, 2014).
Although photoreceptor-speciﬁc proﬁling of ncRNA species is
yet to be conducted, dynamic regulation of speciﬁc ncRNAs has
been reported during retinal development and disease. In silico, RT-
PCR and in situ hybridization studies have revealed spatio-temporal
expression of miRNAs in the developing and mature retina (Arora
et al., 2010; Deo et al., 2006; Hackler et al., 2010; Karali et al.,
2010; Ryan et al., 2006; Xu, 2009). In addition, miRNAs exhibit
altered expression during circadian cycle (Krol et al., 2010; Xu et al.,
2007), cell survival (Damiani et al., 2008; Lumayag et al., 2013;
Sundermeier et al., 2014), and in disease conditions (Loscher
et al., 2008; Shen et al., 2008). The effect of miRNAs at the inter-
section of several GRN is exempliﬁed by the “miR-96, miR-182 and
miR-183” cluster, which contributes to circadian regulation of gene
expression in the retina and has a more general role in neurosen-
sory cell-speciﬁc GRNs (Xu et al., 2007).
Eighteen lncRNAs are highly conserved in mammalian eyes; of
these, fourteen are expressed in the macular region and others in
rest of the retina (Mustaﬁ et al., 2013). Furthermore, lncRNAs are
shown to play a role in retinal development (Rapicavoli and
Blackshaw, 2009); e.g., in regulation of cell cycle (Vax2os1), mod-
ulation of transcription factor activity (Six3OS), and speciﬁcation of
cell fate (RNCR2) (Meola et al., 2012; Rapicavoli et al., 2010, 2011),
highlighting their potential involvement in GRNs. As transcriptome
databases expand, functional studies of existing and newly-
identiﬁed small and lncRNAs will provide novel insights into their
role in ﬁne-tuning GRNs.
3.2.6. Proteome analysis
Transcriptome analysis does not accurately represent protein
expression in a cell or tissue since protein content is also regulated
by translational and post-translational events and reﬂects the
equilibrium between synthesis, stability and degradation. Complex
proteineprotein interactions add another level of complexity to
how cellular physiology and homeostasis are controlled. Protein
proﬁles of the retina (Barnhill et al., 2010; Finnegan et al., 2008)
have been generated using mass spectrometry, validating the
presence of a multitude of retinal proteins as previously predicted
by microarray results. Studies have also reported photoreceptor-
enriched proteome acquired from planar cryosections of the
photoreceptor layer (McKay et al., 2004) or rod outer segment disk
puriﬁcation (Elliott et al., 2008; Kwok et al., 2008; Panfoli et al.,
2008). However, global proteomic methodologies are more quali-
tative than quantitative and not suitable for the analyses that
require high detection sensitivity and comprehensiveness as in
genomics approaches. Micro-scale detection techniques are being
developed for protein analysis. Quantiﬁcation of protein expression
using nanopore technology (Wei et al., 2012b), single protein
molecule counting on a two-dimensional surface (Tessler et al.,
2009), and single cell western blotting (Hughes et al., 2014) are
among promising new technologies, which can potentially be
adapted for increased throughput.
A targeted proteomic approach has now begun to provide in-
sights into photoreceptor gene regulation. A recent study focused
on NRL-containing transcriptional complexes and identiﬁed the
transcription-splicing protein, NonO, and other binding partners of
NRL as important regulators of rod gene expression (Yadav et al.,
2014). We should note that translation of mRNA into protein has
been successfully monitored indirectly through ribosomal proﬁling
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approaches would also be valuable to complement gene expres-
sion proﬁling and epigenome data. More targeted or global pro-
teomic analysis is expected to completely deﬁne photoreceptor
GRNs.
4. System-level analysis of retinal aging
Aging in higher organisms reﬂects the interplay of genetic fac-
tors with the environment and inﬂuence of stochastic events
(Fig. 5); this requires investigation(s) of interaction networks un-
derlying biological processes rather than focus on a single gene or
protein (Kriete et al., 2006). Although aging does not cause a clinical
disease per se, phenotypes of aging can resemble disease pheno-
types. Conversely, aging-associated changes increase vulnerability
and instability of the system, making it more susceptible to further
damage and to the effects of genetic mutations. Thus, aging is a
leading risk factor for several common late-onset diseases. In this
section, we explore genome-wide studies of aging as a time-
dependent event relevant for eye function and pathology, with
focus on the retina.
Each component of the eye contributes differently to overall
decline in visual function with aging. Progressive deterioration in
retinal anatomy (Curcio, 2001; Curcio et al., 1993; Gao and
Hollyﬁeld, 1992) and psychophysical parameters (Birch and
Anderson, 1992; Bonnel et al., 2003; Freund et al., 2011;
Shinomori and Werner, 2012) is observed with advanced age.
Structural and functional changes have also been reported in
photoreceptors (Curcio, 2001; Gresh et al., 2003; Kolesnikov et al.,
2010; Parapuram et al., 2010; Samuel et al., 2011).
4.1. Expression proﬁling of aging retina
Systems biology of the aging retina starts with gene expression
proﬁling to detect chronological events that alter cellular homeo-
stasis (Table 3). Early studies were performed using SAGE (Sharon
et al., 2002) or microarray platforms (Cai et al., 2012; Chowers
et al., 2003b; Yoshida et al., 2002) on post-mortem human ret-
inas, which have inherent variability associated with individual
genetic variations, pre- and post-mortem conditions, and quality of
RNA. Little to no concordance among studies was observed at the
gene level, due to differences in samples, platforms and analyses.
However, when genes are considered in the context of ontologies
and gene networks, characteristic patterns begin to emerge in the
aging retina, suggesting a general metabolic slow down (Cai et al.,
2012; Chowers et al., 2003b; Yoshida et al., 2002) and decrease in
expression of phototransduction genes (Chowers et al., 2003b;
Sharon et al., 2002). Genes associated with stress response and
inﬂammation are generally up-regulated (Cai et al., 2012; Chowers
et al., 2003b; Yoshida et al., 2002), thus highlighting manifestations
of retinal aging that are shared with the brain (Lee et al., 2000).
Notably, there appears to be a trend towards increased expression
in older age of extracellular matrix genes, with relevance to the
ontogenesis of AMD (Chowers et al., 2003b) and differential aging
mechanisms in the macula compared to the peripheral retina (Cai
et al., 2012).
Some of the variability reported by the human studies can be
overcome by molecular studies of aging in mouse. Comparison of
two senescence-accelerated mouse prone strains (SAMP8 and
SAMP10) to the senescence-accelerated mouse resistant strain
(SAMR1) and the commonly inbred C57Bl/6J strain using Affyme-
trix™ oligonucleotide microarrays (Table 3) has highlighted the
strong genetic background effect on the transcriptional response to
aging (Carter et al., 2005). Expression of genes involved in inﬂam-
mation and response to injury/stress is higher in aging mouseretina (Chen et al., 2010a), in concordance with the studies on
human aging and with SAMR mice.
A limitation of gene expression data in the aging retina is that
it represents average changes in six neuronal and two glial cell
types, which contribute differently to tissue homeostasis. While
these data may provide insights into the behavior of the system
at the tissue level, expression proﬁling of the aging mouse rod
photoreceptors (Parapuram et al., 2010) and of microglia (Ma
et al., 2013) has expanded our understanding at the cellular
level. Notably, genes associated with inﬂammatory signaling and
stress response pathways constitute predominant hubs in
network analysis of photoreceptor aging data (Parapuram et al.,
2010). Furthermore, expression of genes involved in oxidative
phosphorylation is reduced in aging photoreceptors (Barb et al.,
manuscript in preparation), highlighting an age-related
pathway that was not detected by whole retina studies but is a
common feature of aging (de Magalhaes et al., 2009). Finally,
angiogenesis and retinoid/lipid metabolism (regulated through
signaling from the retinoic acid receptor) have emerged as unique
pathways to rod photoreceptor aging (Parapuram et al., 2010).
Focusing on photoreceptors as a single cell type, the question is
whether gene expression changes observed in aging are intrinsic
or an adaptive response to modiﬁcation of retinal microenvi-
ronment, and whether these changes are protective, permissive
or causative of the functional decline (Parapuram et al., 2010).
Transcriptome analysis of isolated aging microglia shows changes
in genes involved in cell metabolism, shape and motility, and in
neurotrophic signaling, which could compromise the supporting
role of microglia in the retina (Ma et al., 2013). Furthermore,
expression changes in genes associated with microglia activation
and inﬂammatory signaling suggest a contribution to the general
retinal neuro-inﬂammatory process (von Bernhardi et al., 2010;
Xie et al., 2003). As in case of rod photoreceptors, expression
changes also affect genes involved with lipid metabolism and
angiogenesis. The latter underscores the complexity of angio-
genic events in AMD, in which signaling from multiple cell types,
including RPE, photoreceptors and microglia, may converge to
determine pathological changes, further demonstrating the
importance of approaching retinal aging from a systems biology
perspective.
From existing expression data, it is reasonable to assume that
aging involves small changes in several genes that contribute to
common pathways rather than major changes in individual genes.
It becomes therefore critical to detect even small expression shifts
with good statistical conﬁdence. RNA-seq using NGS, with much
higher reproducibility and greater dynamic range compared to
microarray, is the ideal platform for more in depth molecular
studies of retinal aging. RNA-seq has been employed in expression
studies of human and mouse retina, however, not in relation to
aging (Brooks et al., 2012; Farkas et al., 2013; Gamsiz et al., 2012;
Li et al., 2014). One RNA-seq study so far published in the aging
retina investigates the senescence-accelerated OXYS rats
compared to Wistar controls (Kozhevnikova et al., 2013). Because
of the profound pathological phenotype observed in the OXYS rats,
it is difﬁcult to distinguish aging from overt strain-dependent
disease. However, differential expression of genes between 3 and
18 month old Wistar rats shows signiﬁcant down-regulation of
genes associated with extracellular matrix, response to nutrient
levels and aminoacyl-tRNA biosynthesis, together with up-
regulation of genes encoding negative regulators of transcription
and components of synaptic transmission pathways. Immune
response genes appear in both up-regulated and down-regulated
gene ontologies, suggesting potentially impaired immune func-
tion in the aging rat retina, similar to the ﬁndings by microarrays
in mouse and human.
Fig. 5. Interface between aging and disease. The environment inﬂuences photoreceptor homeostasis throughout life. The cell adaptive response helps maintain a balanced ho-
meostasis. As the adaptive response becomes insufﬁcient to overcome “insults” to the system, damage accumulates in aging photoreceptors. Major metabolic failure is observed for
the ubiquitin-proteasome system and mitochondria. Epigenetic changes and stochastic changes in gene expression combined with the presence of susceptibility variants, eventually
tilt the equilibrium towards the disease state. At which point, inﬂammation and angiogenesis become pathologic, further aggravating disease manifestations.
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The scenario emerging from gene expression analyses of the
aging retina is one of a tissue that is metabolically slowing down,
activates stress and signaling pathways, and presents a complex
immune and inﬂammatory activity. Because of the nature of aging,
data collection from the same individual over time would be ideal
but it is not a viable option for the retina. For human studies, a
random selection of subjects from different age groups (post-
mortem donors) suffers from large individual variations that can
only be overcome if enough replicates can be collected and if
experimental variables are minimally altered. This underscores the
importance of strict collection and transportation protocols that
minimize the time from death to enucleation and processing.
Eliminating technical variability becomes even more critical if one
wants to take an unbiased approach and use principal component
analysis (PCA) to partition the samples between young and old on
the ﬁrst component.
RNA-seq has revealed the expression of novel transcripts and
genes in the retina (Farkas et al., 2013; Gamsiz et al., 2012; Li et al.,2014) suggesting the need to extend this analysis to aging indi-
vidual cell types in mouse and, where possible, in human. In depth
analysis of RNA-seq data will allow the identiﬁcation and study of
emergingmodulators of aging such as regulatory ncRNAs described
in Section 3.2.5 (reviewed in Montano and Long, 2011). Repro-
ducibility of RNA-seq will also facilitate compilation of different
studies to increase sample number and statistical signiﬁcance.
Finally, comprehensive cross-comparisons of existing databases
(Table 2) should provide deeper insight than that achieved by in-
dividual analyses.
5. Systems biology of retinal degeneration
Retinal degenerative diseases (RDDs) are genetically heteroge-
neous, ranging frommonogenic forms such as retinitis pigmentosa
to complex disorders such as AMD. Since the ﬁrst linkage analysis
that identiﬁed a genomic locus associated with X-linked retinitis
pigmentosa (Bhattacharya et al., 1984), we have witnessed a
remarkable progress in elucidating the genetic basis of retinal
diseases (Swaroop and Sieving, 2013; RetNet, http://sph.uth.edu/
Table 3
Gene expression proﬁling studies of aging ocular tissues.
Organism Tissue/cell type Platform Number of genes Age range Reference
Human Neural retina/macula
and periphery
SAGE 320,998 tags 44e88 yr (Sharon et al., 2002)
Human Neural retina Microarray, Micromax 2400 probes 13e72 yr (Yoshida et al., 2002)
Human Neural retina Microarray, Custom 10,034 genes 29e90 yr (Chowers et al., 2003a)
Human Neural retina/macula
and periphery
Microarray, Affymetrix Human
Genome U133 plus 2
54,600 gene probes 18e79 yr (Cai et al., 2012)
Mouse Neural retina Microarray, Agilent
Technologies, Whole Mouse
Genome Oligo Microarrays
4  44K
43,379 gene features 3e20 mo (Chen et al., 2010a)
Mouse -senescence Neural retina Microarray, Affymetrix
MG_U74Av2 GeneChip
36,000 full-length genes
and EST clusters
3e21 mo (Carter et al., 2005)
Mouse Rod photoreceptors
(ﬂow-sorted Nrlp-EGFP retina)
Microarray, Affymetrix Mouse
Exon 1.0ST Array GeneChip
>28,000 coding, >7000
non-coding transcripts
1.5e12 mo (Parapuram et al., 2010)
Mouse Microglia (ﬂow- sorted,
CD11b-immunopositive cells)
Microarray, Affymetrix Mouse
Exon 1.0ST Array GeneChip
>28,000 coding, >7000
non-coding transcripts
3e24 mo (Ma et al., 2013)
Rat - senescence Neural retina RNA-Seq, Illumina GA IIx 15,300 identiﬁed transcriptsa 3e18 mo (Kozhevnikova et al., 2013)
a Approximate number of transcripts detected in at least three samples with FPKM > 1.
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(Wright et al., 2010). Functional analyses of the identiﬁed disease
genes through cell-based and animal models have enhanced our
understanding of their normal function in ocular development and
homeostasis. However, elucidation of underlyingmechanism(s) has
not kept pace with disease gene identiﬁcation.
The advent of NGS is now transforming, at an unprecedented
rate, the way we study genetic basis of human disease. Holistic
approaches to RDDs have become possible through a combination
of NGS-based strategies including disease-associated variant
identiﬁcation, transcriptome analysis, and high throughput search
for biomarkers (Fig. 6). We can learn about regulatory networks,
disease-relevant pathways and their crosstalk, which can be
invaluable for translational and personalized medicine. In this
section, we discuss the following areas, which will provide the
necessary impetus:
(i) Whole exome and whole genome sequencing (WES and
WGS) of patients with monogenic RDDs for better genoty-
peephenotype correlation and search for genetic modiﬁers
(ii) Fine mapping and functional dissection of associated loci
(iii) Genetics of RDDs beyond genetic variants5.1. NGS applications for disease variant/mutation discovery
NGS methods have expedited the process of cataloging human
genetic variation. While precise correlation of variants associated
with disease phenotypes is still challenging, NGS approaches, such
as WES, WGS and targeted sequencing, have become preferred
methods for disease gene discovery (Fig. 7A). A number of novel
genes have been identiﬁed through WES in small Mendelian RDD
families and in sporadic cases that were not suitable for customary
linkage studies (Ratnapriya and Swaroop, 2013).
Progress in dissecting genetic architecture of complex RDDs has
been relatively slow since these multifactorial diseases are more
common in the population and often do not exhibit familial
segregation. Furthermore, non-genetic factors, such as environ-
ment, can contribute to disease onset and severity. We have come a
long way since the initial association of CFH variant with AMD
(Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005;
Jakobsdottir et al., 2005; Zareparsi et al., 2005a). A total of 19
AMD susceptibility loci have been detected so far, including 7 new
loci identiﬁed in the meta-analysis of 17,000 cases and 60,000
controls (Fritsche et al., 2013). These discoveries have providedclues about the underlying disease processes and have implicated
complement cascade, high-density lipoprotein cholesterol and
extracellular matrix pathways in AMD pathogenesis (Fritsche et al.,
2014; Priya et al., 2012). However, associated locus variants are
usually not causal and often reside outside the gene region. Thus,
more than one gene at each associated locus can be potential dis-
ease gene. The nature of causal variants/genes at these loci remains
debatable and needs further explorations as the causal variants
could be an associated variant, another common variant, a rare
variant or even a structural variant (Fig. 7B).
Identiﬁcation of rare variant(s) in a speciﬁc gene at the associ-
ated locus can provide functional clues. For AMD, a rare penetrant
mutation, R1210C was ﬁrst identiﬁed at the CFH locus
(Raychaudhuri et al., 2011). Subsequently, rare variants in several
complement pathway genes have been associated with AMD
through targeted and whole genome sequencing (Helgason et al.,
2013; Seddon et al., 2013; van de Ven et al., 2013; Yu et al., 2014;
Zhan et al., 2013). However, the search for rare variants in RDDs
has been limited to known loci and candidate association regions.
Whole exome and whole genome sequencing studies in large pa-
tient cohorts may facilitate cataloging of rare and common causal
variants, identiﬁcation of novel disease genes and assist in biolog-
ical investigations. However, rare variant association study design
requires a large sample size since, as predicted, not many in-
dividuals will harbor a rare variant. Genetic reﬁnement of associ-
ated signals with improved imputationmethods can further help in
identifying potential causal variants. Recently, a new SNP array
(“exome-chip”) was developed to explore the role of common as
well as rare variants in complex traits (Huyghe et al., 2013). Sixteen
additional AMD loci have now been identiﬁed by exome-chip
analysis and imputation of variants in approximately 26,000
cases and 22,000 controls (Cipriani and International AMD
Genomics Consortium, 2014; Fritsche and International AMD
Genomics Consortium, 2014). Notably, only a small number of
rare variants were identiﬁed in this study, and whole genome
sequencing might be necessary for evaluating the role of rare var-
iants in AMD.
5.2. Less-recognized complexities associated with genetic variations
and human retinal diseases
Human genome harbors a large number of genetic variations,
and NGS has made it possible to systematically catalog genome-
wide sequence variants. However, methods for distinguishing a
neutral variant from the causal one are not yet fully established.
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and nucleotide conservation across species. However, these
criteria do not seem sufﬁcient as we are learning more about the
architecture of variants in the human genome. A single human
genome can harbor thousands of variants (10,000e11,000
non-synonymous and 10,000e12,000 synonymous variations)
(Genomes Project Consortium et al., 2012), with as many as 300
loss-of-function alleles having little or no clinical consequence
(Kukurba et al., 2014; MacArthur et al., 2012). Incorrect assign-
ment of variants can have immediate implication for diagnosis,
therapeutic advice and research direction. The recommendations
for identifying causal genes/variants associated with speciﬁc
phenotypes through NGS studies have been reviewed recently
(Chakravarti et al., 2013; MacArthur et al., 2014; Samocha et al.,
2014). Here, we revisit some of the issues that have implications
for retinal genetics.5.2.1. Are mutations rare genetic variations?
Mutations causing monogenic diseases are believed to be rare,
and often a blanket minor allele frequency cut-off is applied to ﬁlter
out disease variants. Such an approach can miss cases where dis-
ease variants are common and/or likely modify the disease
phenotype (Ebermann et al., 2010; Khanna et al., 2009; Louie et al.,
2010; Venturini et al., 2012). Notably, carrier frequency of the null
mutations responsible for RDDs is unusually high in general pop-
ulation (Nishiguchi and Rivolta, 2012). A vast majority of known
genetic variants associated with complex diseases (such as AMD)
are common and yet some may have functional relevance to pa-
thology (such as Y402H in CFH). As investigations of genetic vari-
ation underlying complex traits continue to mature, we are seeing
examples of rare and common regulatory as well as copy number
variants associated with disease. Thus, no general analysis pipeline
should be applied to identify the variants of interest, and one must
customize based on genetic architecture of the disease under study.Fig. 6. Integration of multi-level data sets for system-level understanding. Simultaneous an
multi-dimensional view of the system and can help identify pathways and networks that
biology as well as to identiﬁcation of disease associated nodes, which can be potential dru5.2.2. Do disease-causing mutations have to be conserved?
Computational prediction tools incorporate evolutionary con-
servation across species as a criterion when assigning causality to
variants. While a majority of disease-related variants follow this
pattern, less conserved residues, silent variants or changes in the
non-coding region have also been implicated in disease (Cartegni
et al., 2002; Sauna and Kimchi-Sarfaty, 2011). Furthermore, the
effect of a variant is likely to be inﬂuenced by size, polarity, codon-
usage, neighboring amino-acid residues and location with respect
to the overall protein conformation. Prediction programs fail to
account for many of these important parameters. Thus, ﬁltering out
any “potentially interesting” variant based on prediction criteria
should not be a common practice. Development of more sophisti-
cated analytical tools is therefore necessary for better predictive
power.5.2.3. Are monogenic diseases caused by defects in only one gene?
Until recently, a majority of disease genes for monogenic
traits have been identiﬁed through traditional linkage approach,
where loci that segregate with the disease phenotype are
screened for mutation(s) in candidate genes. Once a segregating
disease mutation is identiﬁed, the researchers usually no longer
search for mutations/variations. However, extensive genetic and
even phenotypic heterogeneity observed in RDDs has been an
obstacle to diagnosis and counseling. Different RDDs also share
overlapping clinical ﬁndings; thus, mutations in many different
genes may result in similar phenotypes and/or mutations in one
gene can lead to distinct phenotypes. In Mendelian diseases,
inheritance of a genetic defect implies that one will get the
disease. However, many individuals carrying a mutation may
show no clinical phenotype (incomplete penetrance) or variable
expressivity. As every individual carries thousands of unique
variants, one can envisage compensatory variations in inter-
acting genes (epistasis) that can alter the clinical phenotype(s)alysis of genomics, transcriptomics and proteomics data can provide a comprehensive
are speciﬁc to development and disease. This can lead to better understanding of the
g targets (e.g., hub depicted as a purple node in the example network).
Fig. 7. General recommendations for genetic analysis of monogenic and complex diseases using next-generation approaches. A. Families with a monogenic (i.e., Mendelian) disease,
even those with a small number of individuals, can be analyzed by whole exome or genome sequencing. In case of identiﬁcation of mutation(s) in a novel gene, additional validation
is required, including genetic analysis of more families/patients as well as functional analysis using animal models to understand the role in disease causation. For complex diseases,
genome wide association study is performed on a large number of samples including patients and population-matched controls, to identify common susceptibility variants
associated with the disease. Targeted sequencing, whole exome or genome sequencing can be applied to identify the causal variant at the susceptibility locus. Finally, multiple
molecular genetic and cellular assays as well as studies in animal models are required to identify functional variants underlying trait association. WES, whole exome sequencing;
WGS, whole genome sequencing, GWAS, genome-wide association study. B. Schematic representation of follow-up on a GWAS hit to identify the causal gene/variant. Causal variants
could be common regulatory variants, rare coding variants or copy number variants. Targeted sequencing around the associated locus can help identify the causal variant. Generally,
more than one candidate gene is found at an associated locus, and eQTL analysis in disease relevant tissues can help identify the speciﬁc genotypes affecting gene expression within
the causal gene. Additional functional annotation, including histone modiﬁcations, transcription factor binding sites and DNase I hypersensitivity sites can also help in identifying
the causal gene. Ultimately, a high throughput functional assay in animal and/or cell-based models is highly recommended to understand the role of the gene in disease path-
ophysiology. cM/Mb, centimorgan (cM) per megabase pair (Mb); eQTL, expression quantitative trait locus, TF, transcription factor.
H.-J. Yang et al. / Progress in Retinal and Eye Research 46 (2015) 1e3018(Lehner et al., 2006). Thus, in addition to the “primary” gene
defect, many patients may harbor alleles that can modify the
disease phenotype (modiﬁer alleles). For example, a common
allele in the RPGRIP1L gene, associated with Joubert and Meckel
syndromes (Arts et al., 2007; Delous et al., 2007), is shown to
contribute to retinal degeneration phenotype in individuals
with ciliopathies caused by mutations in other genes (Khanna
et al., 2009). In other instances, mutations in more than one
gene might be necessary to observe a disease phenotype (e.g.,
“digenic” RP caused by ROM1 and RDS alleles) (Kajiwara et al.,
1994). NGS offers an unbiased approach for unveiling genetic
modiﬁers of retinal degeneration across the genome and can
help in reﬁning the genetic deﬁnition of phenotypic variations
in RDD patients.
The spectrum of potentially disease-causing variants makes the
correlation of the variant with the phenotype challenging. Given
that causative variants could be rare, common, regulatory, intronic,silent or compensatory, establishing the role of a gene or a variant
in disease pathogenesis is not straightforward. Genes that are
identiﬁed through genetic studies should be referred as “candi-
dates” until their association with the disease phenotype is vali-
dated by additional evidence including functional data. Further
support can emerge from enrichment of genetic variants (gene-
level evidence) in patients/families compared with controls.
Disruption of the gene in a model system can, in some instances,
reproduce the relevant human phenotype. In addition, one should
be able to rescue the phenotype with the wild type allele but not
with mutant allele(s), thereby mimicking the “Koch's postulates”
(Chakravarti et al., 2013). While mouse (or zebraﬁsh) models do not
always recapitulate the human phenotype, such studies could
provide disease mechanisms and opportunities for evaluation of
treatments (Veleri et al., 2015). Alternative models using patient-
derived human induced pluripotent stem (iPS) cells also appear
promising.
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In addition to common and rare genetic variants, other com-
ponents including copy number variation, epigenetic signature and
geneeenvironment interaction contribute to complex disease
phenotype. While many studies have looked at copy number var-
iations in candidate genes with limited success and replication
(Cantsilieris and White, 2013; Liu et al., 2012), genome-wide sur-
veys have not been useful in identifying such variations associated
with major risk of AMD (Fritsche et al., 2013; Meyer et al., 2011;
Neale et al., 2010; Sobrin et al., 2012).
Epigenetics has gained immense interest because of its role in
human diseases such as cancer (Feinberg et al., 2006). Disease-
related changes include stochastic modiﬁcations in epigenetic
marks as well as local gene-speciﬁc alterations (Pujadas and
Feinberg, 2012). Beyond cancer, epigenetic changes have been
widely associated with human diseases involving chromosomal
abnormalities and intellectual disability (Brookes and Shi, 2014).
Retinal diseases have also been explored for possible involvement
of epigenetic alterations, and genes such as IL17RC (Wei et al.,
2012a) and ApoJ (Suuronen et al., 2007) have been suggested to
contribute to the pathogenesis of AMD. However, such studies
require further validation (Oliver et al., 2013a). More extensive
analysis of the epigenome must be performed using normal or
disease retina (or target cell types).
Complex diseases, such as AMD, exhibit tremendous phenotypic
heterogeneity, andmultiple classiﬁcation and grading systems have
been put forward (Bird et al., 1995; Ferris et al., 2005, 2013).
However, much of the genetic analysis of AMD has been performed
on cohorts with advanced stage of disease, with phenotypes
broadly classiﬁed as geographic atrophy and choroidal neo-
vascularization. While an ARMS2 risk variant is reportedly more
strongly associated to neovascularization compared to geographic
atrophy (Chen et al., 2010b; Sobrin et al., 2011), it has been difﬁcult
to identify genes and pathways associated with distinct clinical
subtypes (Fritsche et al., 2014). The recently completed exome-chip
analysis of the large case-control cohort may provide additional
insights on subtype speciﬁc genetic variants. Whole genome
sequencing of 6000 AMD cases and controls is currently in progress
(Kwong et al., 2014) and should be valuable for deciphering sus-
ceptibility and protective alleles for AMD subtypes.
5.3. Integration of transcriptome with genetic data
Though heritable mutations are present in every cell of an in-
dividual, disease manifestation is often tissue or cell speciﬁc
because of differences in spatio-temporal expression or function of
the responsible gene(s). Thus, it would be important to correlate
genetic variations to gene expression in the retina (or photore-
ceptors) to obtain insights into the regulatory network/pathways
perturbed in RDDs. NGS methods allow high throughput analysis of
genotypes as well as provide an opportunity to sequence all species
of RNA, including the splice variants and relatively less studied
miRNAs and lncRNAs.
A majority of variants associated with complex diseases often
reside outside the coding region of a gene or even in non-
transcribed regions. It is assumed that such variants would have
subtle effects on gene expression or function. The expression
quantitative trait locus (eQTL) analysis combines gene expression
data with genotype information and can assist in identifying risk
alleles (Cheung et al., 2003; Lappalainen et al., 2013). Expression
proﬁling of disease-relevant tissue or cells in case-control sam-
ples may reveal functional variants with biological relevance to
the phenotype. eQTLs are primarily cis-acting, suggesting a
common mechanism at many associated loci (Edwards et al.,
2013). Identiﬁcation of target genes modulated by cis-regulatoryrisk variants will allow better understanding of disease net-
work(s) and/or mechanism(s) through which they act. In fact,
ENCODE project has demonstrated that a large proportion of
associated GWAS SNPs appear to map to functional regulatory
elements (Schaub et al., 2012). As noted earlier, gene expression
patterns are cell type- and tissue-speciﬁc, and eQTL analyses are
more useful in cells/tissue types relevant to the human disease of
interest. The current databases do not include eQTL information
on the retina or other ocular cell types owing to limitations in
obtaining human tissues.
GWAS studies have yielded a large number of new genetic loci
associated with AMD susceptibility. However, several genes that
seem to have biological relevance to AMD pathology have not been
validated even in large GWAS meta-analyses, in part because of
false positive results or phenotypic overlap together with etiolog-
ical heterogeneity; these include ABCA4 (Allikmets, 2000), TLR4
(Zareparsi et al., 2005b), TLR3 (Kleinman et al., 2008; Yang et al.,
2008), CX3CR1 (Tuo et al., 2004), DICER (Kaneko et al., 2011), and
AHR (Choudhary et al., 2014; Kim et al., 2014). Another explanation
could be that the effect size of these variants is small, and much
larger sample size is needed to achieve genome-wide signiﬁcance.
We should also note that the biological signiﬁcance of many genes/
variants identiﬁed by GWAS is not yet clear. The genetic variants
identiﬁed through different approaches may have subtle yet
meaningful inﬂuence on speciﬁc pathways and networks that
when disrupted lead to AMD pathology.We recently suggested that
cumulative impact of few strong or multiple weaker alleles must
reach a threshold of disruption for producing a clinically identiﬁ-
able phenotype (Fritsche et al., 2014). An integrated approach of
spatial and temporal mapping of disease genes and variants onto
the expression data generated from disease-relevant tissues would
be necessary to generate disease-speciﬁc networks. Distinct can-
didates and pathways may converge in networks of co-expressed
genes in disease-relevant cell/tissue at a speciﬁc time. Such dis-
ease networks can help in identifying novel regulatory nodes and
therapeutic targets.
5.4. Approaches for elucidating disease networks
Identifying disease-associated genetic variants is an important
piece of the puzzle in understanding pathogenic mechanism(s).
Rather than examining one gene (and its function) at a given time,
our goal must be to understand the “disease” itself and elucidate
complex interplay among multiple factors (genes, epigenetic
changes, and interacting environment). Initially, one can investi-
gate all genes associated with a retinal disease phenotype (such as
Leber Congenital Amaurosis or AMD) to deduce relevant biological
pathways and then integrate genes and pathways into networks.
For examples, 19 AMD loci, published so far, have implicated
complement, extracellular matrix and lipid metabolism pathways
(Fritsche et al., 2014; Priya et al., 2012). Other studies on GWAS loci
have hinted towards localization of cis-regulatory variation at
enhancer elements (Pennacchio et al., 2013). Integrating high
throughput functional annotations, such as histone marks, tran-
scription factor binding sites and DNase I hypersensitive sites
(DHSs), relevant to AMD cell types can help in prioritization of non-
coding variants at associated loci for subsequent functional evalu-
ation. Combining this information with the genetic data can pro-
vide novel insights into disease mechanisms; for example, exome
sequencing in small families can identify large number of rare and
novel potential disease variants, and ChIP-seq data can allow
ﬁltering of genetic variants, as shown in case of MAK (Ozgul et al.,
2011) where CRX Chip-seq data was used to rank the candidate
genes. Combined systems level analyses of multiple datasets have
already begun to reveal novel insights in disease mechanisms and
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2014; Sahebkar, 2014).
Rare variants or common loci with small effect often require
large sample size to reach genome-wide statistical signiﬁcance.
However, there could be alternate ways to extract meaningful in-
formation about the disease process. For example, exome
sequencing of families where the disease is clustered can identify
rare segregating variants that can impact susceptibility. Enrichment
analysis of candidate variants can either link to existing disease-
associated pathways or reveal novel insights into the disease pro-
cess (Ratnapriya et al., 2014a). Alternatively, pathogenic mecha-
nisms associated with a speciﬁc phenotype within the complex
disease (such as AMD) can also be derived from delineating the
biology of Mendelian RDDs that include overlapping clinical fea-
tures (such as Stargardt disease) (Ratnapriya et al., 2014b).
6. Next generation diagnosis and drug development
The promise of next generation genomics to medicine is exciting
and unprecedented; yet, we have a long way before incorporating
NGS into routine clinical practice. Meanwhile, NGS has created new
opportunities for faster genetic diagnosis that can help in improved
disease management. Given the allelic heterogeneity of RDDs, the
current sequencing methods are not very efﬁcient. Decreasing cost
of sequencing and approval from U.S. Food and Drug Administra-
tion allowing NGSmethods for clinical diagnosis constitute steps in
the rapid realization of personalized medicine. NGS-based
screening methods are now being utilized for RDDs as well (Booij
et al., 2011; Bowne et al., 2011; Neveling et al., 2012; Song et al.,
2011b). The National Ophthalmic Disease Genotyping and Pheno-
typing Network (eyeGene), a CLIA certiﬁed community resource
designed to bring together patients, providers, molecular testing
laboratories and researchers, is incorporating NGS tools for inves-
tigating disease causing mutations (Blain et al., 2013).
Another major application of NGS is in the area of pharmaco-
genomics. Patients with the same disease often respond differently
to drug efﬁcacy and safety because of unique genetic variations
they inherit. Identiﬁcation of large number of susceptibility alleles
has propelled the ﬁeld of pharmacogenomics to a potential future
in personalized medicine. In AMD, the effect of GWAS susceptibility
loci, mainly CFH and ARMS2 variants on treatment outcome of
Avastin (bevacizumab) and Lucentis (ranibizumab), has received a
lot of attention, though such studies have not yielded consistent
results (Hagstrom et al., 2013; Kanoff and Miller, 2013). Small
sample size, incorporation of only few disease markers, and short
term-follow up represent some of the challenges. More compre-
hensive, large-scale prospective studies are necessary to establish
deﬁnitive associations between genotypes and drug response/
efﬁcacy.
Relevance of NGS datasets to development of translational
strategies has been limited so far because of inadequate under-
standing of underlying biology of the disease. GWAS hits are rarely
direct drug targets (Teslovich et al., 2010). Limited predictive value
of the disease models and inability to accurately estimate the efﬁ-
cacy, toxicity and long-term side effects have made discovery of
new drugs very expensive and time consuming (Plenge et al., 2013).
NGS technology has remarkable promise for genomic medicine,
impacting both predictive and preventive medicine. Few studies
have already shown novel means for drug discovery using genetic
data and bioinformatics tools, such as functional annotation, cis-
acting eQTLs and pathway analyses (Okada et al., 2014). We need to
better deﬁne and map interactome networks with its components
(nodes) and interactions (edges) (Vidal et al., 2011). These biological
networks can be integrated with known drug and disease infor-
mation to build drug-target networks (Yildirim et al., 2007). As NGStechnology becomes widely available, pharmacological in-
terventions will have personalized focus on disease treatment.
Identiﬁcation of clinically important variants, together with tran-
scriptome and epigenetic proﬁling, should permit dissection of
human disease genome that is amenable to pharmacological
interventions.7. Challenges and further considerations
Here, we have examined new developments in photoreceptor
biology stemming from NGS technologies. Despite much progress,
challenges remain; these include development of effective bioin-
formatics tools for multi-layer data integration, standardization of
procedures to facilitate collaborativeworks, data sharingwithin the
research community and application of novel ﬁndings from
system-level analysis to develop new hypothesis.7.1. Multi-layer data integration
Most high throughput data generation and analysis have so far
been conducted at one or two layers of biological information. For
instance, transcriptome analysis has been the most dominant
form of genome-wide information, and other types of data such as
transcription factor targetome or epigenome proﬁling have been
individually compared to transcriptome data but not to one
another. With increasing amount of studies examining various
layers of biological pathways, including regulatory RNAs, epi-
genome and proteome, the resulting higher order integrative
analysis is expected to further reﬁne the current knowledge of
molecular networks. To this end, applying robust computational
analysis of the data sets is critical. The large-scale ENCODE
(encyclopedia of DNA elements) consortium probably provides
the best model. Upon completion of the human genome project,
ENCODE was launched to investigate functional elements of hu-
man andmouse genome (http://encodeproject.org). By employing
more than two-dozen assays, a large number of data sets have
been generated from 147 distinct cell types or tissues (ENCODE
Project Consortium, 2012). Several powerful software tools were
developed with a goal of effective data integration across het-
erogeneous data sets (http://encodeproject.org/ENCODE/
encodeTools.html). Additional open source bioinformatics tools
are freely available.7.2. Standardization of procedures and quality control
Given the signiﬁcant amount of expertise, workloads, and
funding required for high throughput data collection, the prac-
tice of comprehensive and multi-dimensional data analysis de-
mands collaboration among various disciplines. Independently
generated data sets will often have to be compiled together for
integrative analysis. The vision research community, therefore,
needs standardized procedures for experimentation and data
analysis. Detailed instructions for high throughput assay pro-
tocols and quality control are also provided as a part of the
ENCODE project (ENCODE Project Consortium, 2011), and all the
upcoming data generation should refer to those. The retina,
however, consists of highly specialized sets of neurons and
supporting cells; thus, additional guidelines speciﬁc to the vision
ﬁeld must be implemented. Directions and relevant resources for
retinal sample preparation should be established. As retina is
rich with tissue-speciﬁc transcript isoforms, genome annotations
tailored for the retina should be established for standardized
data analysis.
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A fundamental consideration for systems approaches is to
facilitate data sharing. High throughput studies are unique in that
the generated data can be re-analyzed to discover new patterns and
to test new hypotheses distinct from those posed in the original
study. Therefore, after the initial analysis and publication, high
throughput data sets should be readily accessible for any research
group to view, verify and reanalyze. More than 200 retina-related
data series can be retrieved from public databases, such as Gene
Expression Omnibus (GEO), which archive genome-wide informa-
tion generated by microarray and NGS technologies. Microarray
data deposited to GEO follows, for the most part, the guidelines
from Minimum Information About a Microarray Experiment
(MIAME) (Brazma et al., 2001) put forward by the microarray gene
expression data (MGED) society. However, standardized directions
speciﬁc for NGS data have not been implemented yet, nor the strict
measures for quality control are in place. We have recently un-
dertaken the establishment of a web-based database for retinal
NGS data repository with the following goals:
(i) Implementation of uniform guidelines for sample collection,
assay procedures and data analysis
(ii) Ensure the quality of the deposited data and encourage data
sharing in a timely manner
(iii) Consolidation of high throughput data sets related to retina
(or other ocular tissues) commonly affected in retinal
neurodegenerative diseases
(iv) Provide structured and comprehensive annotation of each
data set
Our archive of high throughput data sets should provide a
critical resource to facilitate higher-order integrated data analysis
and/or novel discovery through re-analysis.Fig. 8. Model of multi-dimensional network of photoreceptors. Networks consist of nodes a
interactions, respectively. The nodes with the greatest number of interactions constitute prim
simultaneously connect with many other nodes, thereby partially mediating the function o
secondary hubs of the network likely poses detrimental impact to the system, while perturb
not exert substantial effect on the system integrity. Identiﬁcation of commonly affected ne7.4. From in silico analysis to the bench
The observations made from system-wide analyses, in most
instances, are descriptive and hypothesis-generating rather than
hypothesis-testing. Wet bench research is needed to verify and
further develop the knowledge obtained from systems level
computational analyses. Networks and/or patterns implicated in
retinal development, aging or disease must be tested by traditional
in vivo and in vitro model systems. The three-dimensional retinal
cultures derived from human or mouse stem cells (Eiraku et al.,
2011; Nakano et al., 2012) provide a useful model for human
retina in the context of evaluating the role of microenvironment
and genetic pathways. Patient-speciﬁc induced pluripotent stem
cells provide hope for the development of personalized medicine.
8. The future of systems biology approaches: biology of the
organism as a whole
In this review, we have primarily focused on GRNs that maintain
photoreceptor function and on RDDs; nonetheless, we do realize
that a comprehensive systems biology strategy would also incor-
porate population-wide genetic variations, protein interaction
networks and metabolomics. In general, we believe that repro-
ducible topologies in the networks with principal regulators would
constitute the hubs of sub-networks. It is not difﬁcult to imagine
that perturbation of such primary hubs (e.g., key regulators, rate-
limiting substrates and enzymes) likely imposes more pro-
nounced impact on photoreceptor health than the defect in locally
conﬁned nodes with fewer interactions (e.g., those with limited
physiological reach) (Fig. 8). Targeting “key” hubs would therefore
represent an attractive strategy for drug discovery.
One of the major bottlenecks in therapeutic development has
been the overwhelming number of disease-associated nodes (i.e.,
disease genes) due to heterogeneity of RDDs. As suggested earliernd edges, representing cellular components (genes, transcripts, proteins, etc.) and their
ary hubs. Secondary hubs themselves are the interacting partners of primary hubs and
f the primary hubs. Local sub-networks are also prevalent. Perturbation of primary or
ation of a more locally conﬁned network or a node with few interacting partners may
tworks in diverse retinal diseases will allow the better drug design.
H.-J. Yang et al. / Progress in Retinal and Eye Research 46 (2015) 1e3022(Swaroop et al., 2010; Yu et al., 2004b), it is conceivable that distinct
mutations resulting in a broad spectrum of retinal diseases
converge onto a manageable number of “key” hubs (with over-
lapping disease-associated pathways/networks) prior to photore-
ceptor death. Thus, one may not need to target individual disease
causing genes to rescue photoreceptor integrity. Identiﬁcation of
common retinal disease-related networks and associated hubs may
now be within reach for discovering better drug targets.
We have come a long way in deﬁning the biology of individual
genes. Nonetheless, we now must provide an appropriate cellular
context to individual genes and their functional products. We have
already started to examine genetic, transcriptional and epigenetic
architectures and await integrated analysis to incorporate prote-
ome and metabolome data. Networks constructed from multi-
dimensional data analysis will simulate functional and physiolog-
ical outcome of photoreceptors in response to alteration in the
microenvironment and variations in the genetic makeup. Human
genomes are highly polymorphic, and evenmonozygotic twinsmay
carry genetic differences (Bruder et al., 2008). Notably, individuals
are estimated to carry over 2500 functionally relevant genetic
variations (Genomes Project Consortium et al., 2012). Such vari-
ability is what makes each of us unique and would be expected to
inﬂuence the network structure. Genetic polymorphism, together
with aging and environmental stress, may have profound impact on
susceptibility to diseases and drug response. The holistic ap-
proaches thus have the key to accurate diagnosis and personalized
medicine.
In this review, we have primarily discussed system-level anal-
ysis of the whole cell (rather than focusing on a gene or a pathway
in isolation). We recognize that cells in higher organisms do not
function independently but constitute higher order structures that
are morphologically and functionally distinct (e.g., retina, lens,
cerebellum), which in turn are in constant communication with
structures farther away (e.g., via systemic circulation or neuronal
connectivity). Thus, aberrant function of a gene in a speciﬁc cell
may have wide-ranging impact on other tissues and the whole
organism. A true system-level analysis will eventually incorporate
both limited and long-range effects on GRNs and cell function. The
retinal research has an exciting future, as we are closer to better
predictive and treatment strategies for every individual.
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